In this study we investigated the serum VEGF level ( s - VEGF) in patients with renal cell carcinoma ( RCC).	"serum	34	39	Organism_substance"	"VEGF	40	44	Gene_or_gene_product"	"VEGF	57	61	Gene_or_gene_product"	"patients	66	74	Organism"	"renal cell carcinoma	80	100	Cancer"	"RCC	103	106	Cancer"	"[{""token"": ""serum"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""renal cell carcinoma"", ""start_span"": 80, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""RCC"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Cancer""}]"
s - VEGF in peripheral blood samples was analyzed in 40 RCC patients and 40 patients without cancer ( controls) using a sandwich enzyme - linked immunoassay.	"VEGF	4	8	Gene_or_gene_product"	"peripheral blood samples	12	36	Organism_substance"	"RCC	56	59	Cancer"	"patients	60	68	Organism"	"patients	76	84	Organism"	"cancer	93	99	Cancer"	"[{""token"": ""VEGF"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""peripheral blood samples"", ""start_span"": 12, ""end_span"": 36, ""type"": ""Organism_substance""}, {""token"": ""RCC"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Cancer""}]"
The results indicate that tumor tissue of RCC liberates VEGF into the systemic blood flow and that s - VEGF is a possible marker for RCC.	"tumor tissue	26	38	Tissue"	"RCC	42	45	Cancer"	"VEGF	56	60	Gene_or_gene_product"	"blood	79	84	Organism_substance"	"VEGF	103	107	Gene_or_gene_product"	"RCC	133	136	Cancer"	"[{""token"": ""tumor tissue"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Tissue""}, {""token"": ""RCC"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""RCC"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Cancer""}]"
To examine the mechanisms by which insulin regulates VEGF expression, human retinal pigment epithelial ( RPE) cells were exposed to insulin, and VEGF mRNA levels were quantified with RNase protection assays ( RPAs).	"insulin	35	42	Gene_or_gene_product"	"VEGF	53	57	Gene_or_gene_product"	"human	70	75	Organism"	"insulin	132	139	Gene_or_gene_product"	"VEGF	145	149	Gene_or_gene_product"	"RNase	183	188	Gene_or_gene_product"	"[{""token"": ""insulin"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism""}, {""token"": ""insulin"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""RNase"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"
In vivo nuclear magnetic resonance analysis of tumor blood flow in linomide - treated animals showed localization of blood vessels almost exclusively to the periphery of the poorly vascularized tumors with a significant reduction of both vascular functionality and vasodilation.	"tumor	47	52	Cancer"	"blood	53	58	Organism_substance"	"linomide	67	75	Chemical"	"blood vessels	117	130	Multi"	"tumors	194	200	Cancer"	"vascular	238	246	Multi"	"[{""token"": ""tumor"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""blood"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism_substance""}, {""token"": ""linomide"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""blood vessels"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Multi""}]"
The ras - transformed, ATX - secreting subclones had enhanced motility to ATX as chemoattractant, but there was little difference in the motility responses of NIH3T3 cells transfected with atx, an inactive mutant gene, or empty vector.	"ras	4	7	Gene_or_gene_product"	"ATX	23	26	Gene_or_gene_product"	"subclones	39	48	Cell"	"ATX	74	77	Gene_or_gene_product"	"NIH3T3 cells	159	171	Cell"	"atx	189	192	Gene_or_gene_product"	"[{""token"": ""ras"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""subclones"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""ATX"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""atx"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"
Ciprofloxacin mediated cell growth inhibition, S / G2 - M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.	"Ciprofloxacin	0	13	Chemical"	"cell	23	27	Cell"	"cell	58	62	Cell"	"human	96	101	Organism"	"transitional cell carcinoma	102	129	Cancer"	"bladder cell line	137	154	Cell"	"[{""token"": ""Ciprofloxacin"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""transitional cell carcinoma"", ""start_span"": 102, ""end_span"": 129, ""type"": ""Cancer""}, {""token"": ""bladder cell line"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Cell""}]"
Hence, the down - regulation of p21WAF1, together with the alterations in Bax and cdk2 as observed in our studies, may define a novel mechanism by which ciprofloxacin inhibits tumor cell growth and induces apoptotic cell death.	"p21WAF1	32	39	Gene_or_gene_product"	"Bax	74	77	Gene_or_gene_product"	"cdk2	82	86	Gene_or_gene_product"	"ciprofloxacin	153	166	Chemical"	"tumor cell	176	186	Cell"	"cell	216	220	Cell"	"[{""token"": ""p21WAF1"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""cdk2"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""ciprofloxacin"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""tumor cell"", ""start_span"": 176, ""end_span"": 186, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Cell""}]"
Alpha - melanocyte - stimulating hormone modulates activation of NF - kappa B and AP - 1 and secretion of interleukin - 8 in human dermal fibroblasts.	"Alpha - melanocyte - stimulating hormone	0	40	Gene_or_gene_product"	"NF - kappa B	65	77	Gene_or_gene_product"	"AP - 1	82	88	Gene_or_gene_product"	"interleukin - 8	106	121	Gene_or_gene_product"	"human	125	130	Organism"	"dermal fibroblasts	131	149	Cell"	"[{""token"": ""Alpha - melanocyte - stimulating hormone"", ""start_span"": 0, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 106, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""dermal fibroblasts"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Cell""}]"
By use of electric mobility shift assays, we demonstrate that alpha - MSH ( 10 ( - 6) to 10 ( - 14) M) activates AP - 1 in human dermal fibroblasts, whereas coincubation with interleukin - 1 beta ( IL - 1 beta) results in suppression of its activation.	"alpha - MSH	62	73	Gene_or_gene_product"	"AP - 1	113	119	Gene_or_gene_product"	"human	123	128	Organism"	"dermal fibroblasts	129	147	Cell"	"interleukin - 1 beta	175	195	Gene_or_gene_product"	"IL - 1 beta	198	209	Gene_or_gene_product"	"[{""token"": ""alpha - MSH"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism""}, {""token"": ""dermal fibroblasts"", ""start_span"": 129, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""interleukin - 1 beta"", ""start_span"": 175, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1 beta"", ""start_span"": 198, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
Patients whose tumors were CD40 - negative showed a significantly better N stage, overall stage at presentation and survival than those patients with CD40 - positive patients.	"Patients	0	8	Organism"	"tumors	15	21	Cancer"	"CD40	27	31	Gene_or_gene_product"	"patients	136	144	Organism"	"CD40	150	154	Gene_or_gene_product"	"patients	166	174	Organism"	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""CD40"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""CD40"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Organism""}]"
When BB - 94, a matrix metalloproteinase inhibitor, was added to the culture medium of Ras - expressing cells, it caused a cell aggregation phenotype similar to that caused by TEL expression.	"BB - 94	5	12	Chemical"	"matrix metalloproteinase	16	40	Gene_or_gene_product"	"Ras	87	90	Gene_or_gene_product"	"cells	104	109	Cell"	"cell	123	127	Cell"	"TEL	176	179	Gene_or_gene_product"	"[{""token"": ""BB - 94"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 16, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""TEL"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"
Vasodilator - stimulated phosphoprotein ( VASP) is highly expressed in vascular endothelial cells, where it has been implicated in cellular reorganization during angiogenesis, as well as in endothelial retraction and changes in vessel permeability.	"Vasodilator - stimulated phosphoprotein	0	39	Gene_or_gene_product"	"VASP	42	46	Gene_or_gene_product"	"vascular endothelial cells	71	97	Cell"	"cellular	131	139	Cell"	"endothelial	190	201	Cell"	"vessel	228	234	Multi"	"[{""token"": ""Vasodilator - stimulated phosphoprotein"", ""start_span"": 0, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""VASP"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial cells"", ""start_span"": 71, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Multi""}]"
Further analysis reveals that although LMP1 ( TRADD) promotes cell growth, it does not prevent the eventual onset of senescence and the expression of tumor suppressor p16 ( Ink4a).	"LMP1	39	43	Gene_or_gene_product"	"TRADD	46	51	Gene_or_gene_product"	"cell	62	66	Cell"	"tumor	150	155	Cancer"	"p16	167	170	Gene_or_gene_product"	"Ink4a	173	178	Gene_or_gene_product"	"[{""token"": ""LMP1"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRADD"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""p16"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"
Here we studied the effects of cell morphology on the migration of bovine aortic ECs by culturing cells on micropatterned strips of collagen matrix ( 60 -, 30 -, and 15 - microm wide).	"cell	31	35	Cell"	"bovine	67	73	Organism"	"aortic ECs	74	84	Cell"	"cells	98	103	Cell"	"collagen	132	140	Gene_or_gene_product"	"matrix	141	147	Cellular_component"	"[{""token"": ""cell"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""bovine"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""aortic ECs"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""collagen"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Cellular_component""}]"
Relationship of p53 and Helicobacter pylori to clinicopathological features of human remnant stomach cancer after gastric surgery for primary gastric cancer.	"p53	16	19	Gene_or_gene_product"	"Helicobacter pylori	24	43	Organism"	"human	79	84	Organism"	"remnant stomach cancer	85	107	Cancer"	"gastric	114	121	Organ"	"gastric cancer	142	156	Cancer"	"[{""token"": ""p53"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""Helicobacter pylori"", ""start_span"": 24, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""remnant stomach cancer"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""gastric"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Organ""}, {""token"": ""gastric cancer"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Cancer""}]"
Evi - 1 associates with CtBP1 through one of the CtBP - binding consensus motifs within the region from amino acid 544 to 607, and this association is required for the efficient inhibition of TGF - beta signaling.	"Evi - 1	0	7	Gene_or_gene_product"	"CtBP1	24	29	Gene_or_gene_product"	"CtBP	49	53	Gene_or_gene_product"	"amino acid 544	104	118	Amino_acid"	"607	122	125	Amino_acid"	"TGF - beta	192	202	Gene_or_gene_product"	"[{""token"": ""Evi - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""CtBP1"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""CtBP"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""amino acid 544"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Amino_acid""}, {""token"": ""607"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Amino_acid""}, {""token"": ""TGF - beta"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}]"
Antibodies to PA - 1 dose - dependently, and significantly, inhibited the invasive and migratory potential of human HT1080 fibrosarcoma cells, as did an antibody to uPA and the plasmin inhibitor aprotinin.	"PA - 1	14	20	Gene_or_gene_product"	"human	110	115	Organism"	"HT1080 fibrosarcoma cells	116	141	Cell"	"uPA	165	168	Gene_or_gene_product"	"plasmin	177	184	Gene_or_gene_product"	"aprotinin	195	204	Gene_or_gene_product"	"[{""token"": ""PA - 1"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Organism""}, {""token"": ""HT1080 fibrosarcoma cells"", ""start_span"": 116, ""end_span"": 141, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""aprotinin"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}]"
We also report that SPARC arrests monomeric collagen - supported smooth muscle cell proliferation in the late G1 - phase of the cell cycle in the absence of an effect on cell shape or on levels of cyclin - dependent kinase inhibitors.	"SPARC	20	25	Gene_or_gene_product"	"collagen	44	52	Gene_or_gene_product"	"smooth muscle cell	65	83	Cell"	"cell	128	132	Cell"	"cell	170	174	Cell"	"cyclin - dependent kinase inhibitors	197	233	Chemical"	"[{""token"": ""SPARC"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""collagen"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cell"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""cyclin - dependent kinase inhibitors"", ""start_span"": 197, ""end_span"": 233, ""type"": ""Chemical""}]"
Cyclin - dependent kinase - 2 activity, p107 and cyclin A levels, and retinoblastoma protein phosphorylation are markedly reduced in response to the addition of exogenous SPARC and / or peptides derived from specific domains of SPARC.	"Cyclin - dependent kinase - 2	0	29	Gene_or_gene_product"	"p107	40	44	Gene_or_gene_product"	"cyclin A	49	57	Gene_or_gene_product"	"retinoblastoma protein	70	92	Gene_or_gene_product"	"SPARC	171	176	Gene_or_gene_product"	"SPARC	228	233	Gene_or_gene_product"	"[{""token"": ""Cyclin - dependent kinase - 2"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""p107"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin A"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinoblastoma protein"", ""start_span"": 70, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 228, ""end_span"": 233, ""type"": ""Gene_or_gene_product""}]"
At protein level, VEGF - B and C, Flt - 1, and KDR were not detectable in tissue lysates, whereas VEGF - A was increased in stages III and IV.	"VEGF - B	18	26	Gene_or_gene_product"	"C	31	32	Gene_or_gene_product"	"Flt - 1	34	41	Gene_or_gene_product"	"KDR	47	50	Gene_or_gene_product"	"tissue lysates	74	88	Organism_substance"	"VEGF - A	98	106	Gene_or_gene_product"	"[{""token"": ""VEGF - B"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""C"", ""start_span"": 31, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt - 1"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue lysates"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Organism_substance""}, {""token"": ""VEGF - A"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"
Up - regulation of MMP activity, favoring proteolytic degradation of the basement membrane and extracellular matrix, has been linked to tumor growth and metastasis, as well as tumor - associated angiogenesis, whereas inhibition of MMP activity appears to restrict these processes.	"MMP	19	22	Gene_or_gene_product"	"basement membrane	73	90	Cellular_component"	"extracellular matrix	95	115	Cellular_component"	"tumor	136	141	Cancer"	"tumor	176	181	Cancer"	"MMP	231	234	Gene_or_gene_product"	"[{""token"": ""MMP"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""basement membrane"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Cellular_component""}, {""token"": ""extracellular matrix"", ""start_span"": 95, ""end_span"": 115, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""MMP"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"
Brn - 3a, a member of the POU gene family ( so - called because of the similarity with the group of transcription factors Pit, Oct, and Unc), was found in neuronal cells engaged in the transcription activity of the p1 and p2 promoters of the most powerful antiapoptotic gene, namely, Bcl - 2.	"Brn - 3a	0	8	Gene_or_gene_product"	"Pit	122	125	Gene_or_gene_product"	"Oct	127	130	Gene_or_gene_product"	"Unc	136	139	Gene_or_gene_product"	"neuronal cells	155	169	Cell"	"Bcl - 2	284	291	Gene_or_gene_product"	"[{""token"": ""Brn - 3a"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pit"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Oct"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""Unc"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal cells"", ""start_span"": 155, ""end_span"": 169, ""type"": ""Cell""}, {""token"": ""Bcl - 2"", ""start_span"": 284, ""end_span"": 291, ""type"": ""Gene_or_gene_product""}]"
Although DU145 prostate cancer cells are resistant to exogenously applied Fas agonist CH - 11 ( anti - Fas monoclonal antibody), Fas - resistance can be overcome using a FasL expressing adenovirus ( AdGFPFasL ( TET)) [ Hyer et al., Molecular Therapy, 2000; 2: 348 - 58 ( ref. 12)].	"DU145 prostate cancer cells	9	36	Cell"	"Fas	74	77	Gene_or_gene_product"	"Fas	103	106	Gene_or_gene_product"	"Fas	129	132	Gene_or_gene_product"	"FasL	170	174	Gene_or_gene_product"	"adenovirus	186	196	Organism"	"[{""token"": ""DU145 prostate cancer cells"", ""start_span"": 9, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""Fas"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenovirus"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Organism""}]"
We show that both substitution of glucose for pyruvate and treatment with 2 - deoxyglucose enhanced apoptosis induced by tumor necrosis factor ( TNF) - alpha, CD95 agonistic antibody, and TNF - related apoptosis - inducing ligand ( TRAIL).	"glucose	34	41	Chemical"	"pyruvate	46	54	Chemical"	"2 - deoxyglucose	74	90	Chemical"	"CD95	159	163	Gene_or_gene_product"	"TNF - related apoptosis - inducing ligand	188	229	Gene_or_gene_product"	"TRAIL	232	237	Gene_or_gene_product"	"[{""token"": ""glucose"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""2 - deoxyglucose"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""CD95"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - related apoptosis - inducing ligand"", ""start_span"": 188, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAIL"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"
It involves endothelial cell activation, basal membrane degradation, leukocyte invasion, proliferation of vascular cells, neointima formation ( in most species studied), and changes of the extracellular matrix.	"endothelial cell	12	28	Cell"	"basal membrane	41	55	Cellular_component"	"leukocyte	69	78	Cell"	"vascular cells	106	120	Cell"	"neointima	122	131	Tissue"	"extracellular matrix	189	209	Cellular_component"	"[{""token"": ""endothelial cell"", ""start_span"": 12, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""basal membrane"", ""start_span"": 41, ""end_span"": 55, ""type"": ""Cellular_component""}, {""token"": ""leukocyte"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""vascular cells"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""neointima"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Tissue""}, {""token"": ""extracellular matrix"", ""start_span"": 189, ""end_span"": 209, ""type"": ""Cellular_component""}]"
Injection of indomethacin, a nonselective COX inhibitor, on the day of ovulation and the following day decreased serum levels of progesterone, as did injection of the selective COX - II inhibitor NS - 398.	"indomethacin	13	25	Chemical"	"COX	42	45	Gene_or_gene_product"	"serum	113	118	Organism_substance"	"progesterone	129	141	Chemical"	"COX - II	177	185	Gene_or_gene_product"	"NS - 398	196	204	Chemical"	"[{""token"": ""indomethacin"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""COX"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism_substance""}, {""token"": ""progesterone"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""COX - II"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}, {""token"": ""NS - 398"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Chemical""}]"
Compared with values measured at the edge of the ear and in the contralateral ear, leukocyte adhesion was found to be diminished significantly in vessels inside the ear tumor in both mouse models.	"ear	49	52	Organ"	"ear	78	81	Organ"	"leukocyte	83	92	Cell"	"vessels	146	153	Tissue"	"ear tumor	165	174	Cancer"	"mouse	183	188	Organism"	"[{""token"": ""ear"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Organ""}, {""token"": ""ear"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Organ""}, {""token"": ""leukocyte"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""vessels"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Tissue""}, {""token"": ""ear tumor"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Organism""}]"
Treatment of mice bearing a small ear tumor with a humanized antivascular endothelial growth factor antibody prevented the down - regulation of leukocyte - vessel wall interactions inside the tumor vessels compared with the nontreated group.	"mice	13	17	Organism"	"ear tumor	34	43	Cancer"	"antivascular endothelial growth factor antibody	61	108	Gene_or_gene_product"	"leukocyte	144	153	Cell"	"vessel wall	156	167	Multi"	"tumor vessels	192	205	Multi"	"[{""token"": ""mice"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""ear tumor"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""antivascular endothelial growth factor antibody"", ""start_span"": 61, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukocyte"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Multi""}, {""token"": ""tumor vessels"", ""start_span"": 192, ""end_span"": 205, ""type"": ""Multi""}]"
Fluorescence - activated cell sorter analysis showed that isolated tumor ECs have suppressed levels of intercellular adhesion molecule 1 as compared with ECs from normal mouse tissues.	"cell	25	29	Cell"	"tumor ECs	67	76	Cell"	"intercellular adhesion molecule 1	103	136	Gene_or_gene_product"	"ECs	154	157	Cell"	"mouse	170	175	Organism"	"tissues	176	183	Tissue"	"[{""token"": ""cell"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""tumor ECs"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 103, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Tissue""}]"
In cultured b. END5 cells the tumor necrosis factor alpha - induced up - regulation of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 was reduced in ECs that were preincubated with basic fibroblast growth factor or vascular endothelial growth factor.	"tumor necrosis factor alpha	30	57	Gene_or_gene_product"	"intercellular adhesion molecule 1	87	120	Gene_or_gene_product"	"vascular cell adhesion molecule 1	125	158	Gene_or_gene_product"	"ECs	174	177	Cell"	"basic fibroblast growth factor	206	236	Gene_or_gene_product"	"vascular endothelial growth factor	240	274	Gene_or_gene_product"	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 30, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 87, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 125, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Cell""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 206, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 240, ""end_span"": 274, ""type"": ""Gene_or_gene_product""}]"
Organ biodistribution studies revealed that galectin - 3C localized in the liver, kidneys, and spleen but not in the heart or lungs.	"galectin - 3C	44	57	Gene_or_gene_product"	"liver	75	80	Organ"	"kidneys	82	89	Organ"	"spleen	95	101	Organ"	"heart	117	122	Organ"	"lungs	126	131	Organ"	"[{""token"": ""galectin - 3C"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""kidneys"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Organ""}, {""token"": ""spleen"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Organ""}, {""token"": ""heart"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Organ""}, {""token"": ""lungs"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organ""}]"
We found that the mean tumor volumes and weights were statistically significantly less in mice treated with galectin - 3C compared with control mice, and that fewer numbers of mice exhibited lymph node metastases in the treated group compared with the control group.	"tumor	23	28	Cancer"	"mice	90	94	Organism"	"galectin - 3C	108	121	Gene_or_gene_product"	"mice	144	148	Organism"	"mice	176	180	Organism"	"lymph node	191	201	Multi"	"[{""token"": ""tumor"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Organism""}, {""token"": ""galectin - 3C"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Organism""}, {""token"": ""lymph node"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Multi""}]"
CONCLUSIONS: Galectin - 3C is not overtly toxic, and is efficacious in reducing metastases and tumor volumes and weights in primary tumors in an orthotopic nude mouse model of human breast cancer.	"Galectin - 3C	13	26	Gene_or_gene_product"	"tumor	95	100	Cancer"	"tumors	132	138	Cancer"	"nude mouse	156	166	Organism"	"human	176	181	Organism"	"breast cancer	182	195	Cancer"	"[{""token"": ""Galectin - 3C"", ""start_span"": 13, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""nude mouse"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Cancer""}]"
The effect of wild - type or mutant survivin was investigated on capillary network stability, endothelial cell viability, and caspase activation in vitro and on kinetics of tumor growth and development of angiogenesis in a breast cancer xenograft model in vivo.	"survivin	36	44	Gene_or_gene_product"	"capillary network	65	82	Multi"	"endothelial cell	94	110	Cell"	"caspase	126	133	Gene_or_gene_product"	"tumor	173	178	Cancer"	"breast cancer xenograft	223	246	Cancer"	"[{""token"": ""survivin"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary network"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Multi""}, {""token"": ""endothelial cell"", ""start_span"": 94, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""caspase"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Cancer""}, {""token"": ""breast cancer xenograft"", ""start_span"": 223, ""end_span"": 246, ""type"": ""Cancer""}]"
This was associated with a approximately 60% reduction in tumor - derived blood vessels by quantitative morphometry of CD31 - stained tumor areas, and appearance of endothelial cell apoptosis by internucleosomal DNA fragmentation in vivo.	"tumor	58	63	Cancer"	"blood vessels	74	87	Multi"	"CD31	119	123	Gene_or_gene_product"	"tumor	134	139	Cancer"	"endothelial cell	165	181	Cell"	"DNA	212	215	Cellular_component"	"[{""token"": ""tumor"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""blood vessels"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Multi""}, {""token"": ""CD31"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Cancer""}, {""token"": ""endothelial cell"", ""start_span"": 165, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Cellular_component""}]"
Tail vein injection of N - ( 1 - ( 2, 3 - dioleoyloxy) propyl) - N, N, N - trimethylammonium chloride ( DOTAP) / cholesterol lipoplexes resulted in increased lipoplex entrapment in hypervascularized liver but did not boost luciferase expression, suggesting that lipoplex delivery is not a sufficient condition for efficient organ lipofection.	"Tail vein	0	9	Multi"	"lipoplex	125	133	Chemical"	"liver	199	204	Organ"	"luciferase	223	233	Gene_or_gene_product"	"lipoplex	262	270	Chemical"	"organ	324	329	Organ"	"[{""token"": ""Tail vein"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Multi""}, {""token"": ""lipoplex"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""liver"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Organ""}, {""token"": ""luciferase"", ""start_span"": 223, ""end_span"": 233, ""type"": ""Gene_or_gene_product""}, {""token"": ""lipoplex"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Chemical""}, {""token"": ""organ"", ""start_span"": 324, ""end_span"": 329, ""type"": ""Organ""}]"
Because the intravenously injected lipoplexes migrated within seconds to lungs, we checked whether the effects of immediate contact with serum correlate with lung lipofection efficiency of different DOTAP - based formulations.	"intravenously	12	25	Immaterial_anatomical_entity"	"lipoplexes	35	45	Chemical"	"lungs	73	78	Organ"	"serum	137	142	Organism_substance"	"lung	158	162	Organ"	"DOTAP	199	204	Chemical"	"[{""token"": ""intravenously"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""lipoplexes"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""lungs"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organ""}, {""token"": ""serum"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism_substance""}, {""token"": ""lung"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Organ""}, {""token"": ""DOTAP"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Chemical""}]"
Under conditions mimicking the injection environment, the lipoplex - serum interaction was strongly dependent on helper lipid and ionic strength: lipoplexes prepared in 150 mM NaCl or lipoplexes with high ( greater than 33 mol%) cholesterol were found to aggregate immediately.	"lipoplex	58	66	Chemical"	"serum	69	74	Organism_substance"	"lipid	120	125	Chemical"	"lipoplexes	146	156	Chemical"	"lipoplexes	184	194	Chemical"	"cholesterol	229	240	Chemical"	"[{""token"": ""lipoplex"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism_substance""}, {""token"": ""lipid"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""lipoplexes"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""lipoplexes"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Chemical""}, {""token"": ""cholesterol"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Chemical""}]"
Bone destruction is primarily mediated by osteoclastic bone resorption, and cancer cells stimulate the formation and activation of osteoclasts next to metastatic foci.	"Bone	0	4	Tissue"	"osteoclastic	42	54	Cell"	"bone	55	59	Tissue"	"cancer cells	76	88	Cell"	"osteoclasts	131	142	Cell"	"foci	162	166	Cell"	"[{""token"": ""Bone"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Tissue""}, {""token"": ""osteoclastic"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""bone"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Tissue""}, {""token"": ""cancer cells"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""osteoclasts"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""foci"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Cell""}]"
We report that neuronal death resulting from focal cerebral ischaemia ( middle cerebral artery occlusion, 24 h) is significantly inhibited ( by 50%) in rats injected with a recombinant IL - 1 receptor antagonist ( IL - 1ra, 10 micrograms, icv 30 min before and 10 min after ischaemia).	"neuronal	15	23	Cell"	"cerebral	51	59	Organ"	"cerebral artery	79	94	Multi"	"rats	152	156	Organism"	"IL - 1 receptor antagonist	185	211	Gene_or_gene_product"	"IL - 1ra	214	222	Gene_or_gene_product"	"[{""token"": ""neuronal"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""cerebral"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Organ""}, {""token"": ""cerebral artery"", ""start_span"": 79, ""end_span"": 94, ""type"": ""Multi""}, {""token"": ""rats"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Organism""}, {""token"": ""IL - 1 receptor antagonist"", ""start_span"": 185, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1ra"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Gene_or_gene_product""}]"
We investigated here whether 6 popular antitumor compounds modify the cytotoxic activity of NaF against human squamous cell carcinoma ( HSC - 2) and human promyelocytic leukemia ( HL - 60) cell lines.	"antitumor	39	48	Cancer"	"NaF	92	95	Chemical"	"human	104	109	Organism"	"squamous cell carcinoma	110	133	Cancer"	"human	149	154	Organism"	"promyelocytic leukemia	155	177	Cancer"	"[{""token"": ""antitumor"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""NaF"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 110, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Organism""}, {""token"": ""promyelocytic leukemia"", ""start_span"": 155, ""end_span"": 177, ""type"": ""Cancer""}]"
Bovine lactoferrin, a multifunctional glycoprotein, has been shown to strongly inhibit development of azoxymethane ( AOM) - induced rat colon tumors.	"Bovine	0	6	Organism"	"lactoferrin	7	18	Gene_or_gene_product"	"azoxymethane	102	114	Chemical"	"AOM	117	120	Chemical"	"rat	132	135	Organism"	"colon tumors	136	148	Cancer"	"[{""token"": ""Bovine"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Organism""}, {""token"": ""lactoferrin"", ""start_span"": 7, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""azoxymethane"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Chemical""}, {""token"": ""AOM"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""rat"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""colon tumors"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Cancer""}]"
Immunohistochemical analysis revealed Fas - positive cells and apoptotic cells preferentially within the proximal colon region, clearly at the site of bovine lactoferrin - mediated tumor inhibition.	"Fas	38	41	Gene_or_gene_product"	"apoptotic cells	63	78	Cell"	"colon	114	119	Organ"	"bovine	151	157	Organism"	"lactoferrin	158	169	Gene_or_gene_product"	"tumor	181	186	Cancer"	"[{""token"": ""Fas"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""apoptotic cells"", ""start_span"": 63, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""colon"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organ""}, {""token"": ""bovine"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Organism""}, {""token"": ""lactoferrin"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Cancer""}]"
Pak1 - DLC1 interaction plays an essential role in cell survival, which depends on Pak1 ' s phosphorylation of DLC1 on Ser88.	"Pak1	0	4	Gene_or_gene_product"	"DLC1	7	11	Gene_or_gene_product"	"cell	51	55	Cell"	"Pak1	83	87	Gene_or_gene_product"	"DLC1	111	115	Gene_or_gene_product"	"Ser88	119	124	Amino_acid"	"[{""token"": ""Pak1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""Pak1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ser88"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Amino_acid""}]"
Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase - 2 and - 9 and tissue inhibitor of metalloproteinase - 1 during human dermal wound healing.	"Matrix metalloproteinase	0	24	Gene_or_gene_product"	"matrix metalloproteinase - 2	69	97	Gene_or_gene_product"	"- 9	102	105	Gene_or_gene_product"	"tissue inhibitor of metalloproteinase - 1	110	151	Gene_or_gene_product"	"human	159	164	Organism"	"dermal wound	165	177	Pathological_formation"	"[{""token"": ""Matrix metalloproteinase"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 69, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue inhibitor of metalloproteinase - 1"", ""start_span"": 110, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Organism""}, {""token"": ""dermal wound"", ""start_span"": 165, ""end_span"": 177, ""type"": ""Pathological_formation""}]"
Breast tissue taken at varying postoperative times ( n = 92) or during surgery ( controls, n = 17), was used to investigate the temporal and spatial activity of matrix metalloproteinase - 2 and - 9 and tissue inhibitor of metalloproteinase - 1 during human wound healing.	"Breast tissue	0	13	Tissue"	"matrix metalloproteinase - 2	161	189	Gene_or_gene_product"	"- 9	194	197	Gene_or_gene_product"	"tissue inhibitor of metalloproteinase - 1	202	243	Gene_or_gene_product"	"human	251	256	Organism"	"wound	257	262	Pathological_formation"	"[{""token"": ""Breast tissue"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Tissue""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 161, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue inhibitor of metalloproteinase - 1"", ""start_span"": 202, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 251, ""end_span"": 256, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Pathological_formation""}]"
This finding may be explained by a stimulatory effect of GM - CSF and IL - 3 on ara - C phosphorylating enzymes and a more rapid incorporation of ara - CTP into the DNA of leukemic blasts.	"GM - CSF	57	65	Gene_or_gene_product"	"IL - 3	70	76	Gene_or_gene_product"	"ara - C	80	87	Chemical"	"ara - CTP	146	155	Chemical"	"DNA	165	168	Cellular_component"	"leukemic blasts	172	187	Cell"	"[{""token"": ""GM - CSF"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""ara - C"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Cellular_component""}, {""token"": ""leukemic blasts"", ""start_span"": 172, ""end_span"": 187, ""type"": ""Cell""}]"
We hypothesized that 1) MCT expression in malignant tumors may differ from normal tissue in quantity, isoform, or both; and 2) silencing MCT expression would induce intracellular acidification, resulting in decreased proliferation and / or increased cell death.	"MCT	24	27	Gene_or_gene_product"	"malignant tumors	42	58	Cancer"	"normal tissue	75	88	Tissue"	"MCT	137	140	Gene_or_gene_product"	"intracellular	165	178	Immaterial_anatomical_entity"	"cell	250	254	Cell"	"[{""token"": ""MCT"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant tumors"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""normal tissue"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Tissue""}, {""token"": ""MCT"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 165, ""end_span"": 178, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cell"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Cell""}]"
MCTs that were abundant or specific to glioma then were targeted in the model U - 87 MG glioma cell line via small interfering ribonucleic acid - mediated gene silencing and tested for inhibition of lactate efflux, intracellular pH changes, reduced proliferation, and / or induction of cell death.	"MCTs	0	4	Gene_or_gene_product"	"glioma	39	45	Cancer"	"U - 87 MG glioma cell line	78	104	Cell"	"lactate	199	206	Chemical"	"intracellular	215	228	Immaterial_anatomical_entity"	"cell	286	290	Cell"	"[{""token"": ""MCTs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""U - 87 MG glioma cell line"", ""start_span"": 78, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 215, ""end_span"": 228, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cell"", ""start_span"": 286, ""end_span"": 290, ""type"": ""Cell""}]"
Small interfering ribonucleic acid specific for MCT 1 and 2 reduced expression of these isoforms in U - 87 MG cells to barely detectable levels and reduced lactate efflux by 30% individually and 85% in combination, with a concomitant decrease of intracellular pH by 0. 6 units ( a fourfold increase in intracellular H ( +)).	"MCT 1	48	53	Gene_or_gene_product"	"2	58	59	Gene_or_gene_product"	"U - 87 MG cells	100	115	Cell"	"lactate	156	163	Chemical"	"intracellular	246	259	Immaterial_anatomical_entity"	"intracellular	302	315	Immaterial_anatomical_entity"	"[{""token"": ""MCT 1"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 58, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""U - 87 MG cells"", ""start_span"": 100, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 246, ""end_span"": 259, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intracellular"", ""start_span"": 302, ""end_span"": 315, ""type"": ""Immaterial_anatomical_entity""}]"
Finally, in vivo, in a xenograft model of head and neck squamous cell carcinoma using UM - SCC - 11A cells, 2ME2 exhibited antitumor and antiangiogenic activity, as measured by CD31 immunostaining.	"xenograft	23	32	Cancer"	"head and neck squamous cell carcinoma	42	79	Cancer"	"UM - SCC - 11A cells	86	106	Cell"	"2ME2	108	112	Chemical"	"antitumor	123	132	Cancer"	"CD31	177	181	Gene_or_gene_product"	"[{""token"": ""xenograft"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""head and neck squamous cell carcinoma"", ""start_span"": 42, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""UM - SCC - 11A cells"", ""start_span"": 86, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""2ME2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""CD31"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}]"
Vascular endothelial growth factor ( VEGF), an endothelial cell - specific mitogen, can act in tumor - induced angiogenesis by binding to specific receptors on the surface of endothelial cells.	"Vascular endothelial growth factor	0	34	Gene_or_gene_product"	"VEGF	37	41	Gene_or_gene_product"	"endothelial cell	47	63	Cell"	"tumor	95	100	Cancer"	"surface	164	171	Cellular_component"	"endothelial cells	175	192	Cell"	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""surface"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 175, ""end_span"": 192, ""type"": ""Cell""}]"
Mitochondrial complex II, or succinate dehydrogenase, is a key enzymatic complex involved in both the tricarboxylic acid ( TCA) cycle and oxidative phosphorylation as part of the mitochondrial respiratory chain.	"Mitochondrial	0	13	Cellular_component"	"complex II	14	24	Gene_or_gene_product"	"succinate dehydrogenase	29	52	Gene_or_gene_product"	"tricarboxylic acid	102	120	Chemical"	"TCA	123	126	Chemical"	"mitochondrial	179	192	Cellular_component"	"[{""token"": ""Mitochondrial"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cellular_component""}, {""token"": ""complex II"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""succinate dehydrogenase"", ""start_span"": 29, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""tricarboxylic acid"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""TCA"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Cellular_component""}]"
Similarly, the human INK4B locus encodes the p15 ( INK4B) tumor suppressor and one alternatively spliced form, termed as p10.	"human	15	20	Organism"	"INK4B	21	26	Gene_or_gene_product"	"p15	45	48	Gene_or_gene_product"	"INK4B	51	56	Gene_or_gene_product"	"tumor	58	63	Cancer"	"p10	121	124	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""INK4B"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""p15"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4B"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""p10"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"
Similarly to mouse p15 ( INK4B), p10 expression is also induced by oncogenic insults and transforming growth factor - beta treatment and acts as a cell cycle inhibitor.	"mouse	13	18	Organism"	"p15	19	22	Gene_or_gene_product"	"INK4B	25	30	Gene_or_gene_product"	"p10	33	36	Gene_or_gene_product"	"transforming growth factor - beta	89	122	Gene_or_gene_product"	"cell	147	151	Cell"	"[{""token"": ""mouse"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""p15"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4B"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""p10"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""transforming growth factor - beta"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}]"
Human cervical cancer cells ( CaSki and SiHa) were injected into the flanks of nude mice.	"Human	0	5	Organism"	"cervical cancer cells	6	27	Cell"	"CaSki	30	35	Cell"	"SiHa	40	44	Cell"	"flanks	69	75	Organism_subdivision"	"nude mice	79	88	Organism"	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism""}, {""token"": ""cervical cancer cells"", ""start_span"": 6, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""CaSki"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""SiHa"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""flanks"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Organism_subdivision""}, {""token"": ""nude mice"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Organism""}]"
Tumor sections were stained for: endothelial cells with CD31 and PAS or hypoxia inducible factor 1alpha ( HIF).	"Tumor sections	0	14	Cancer"	"endothelial cells	33	50	Cell"	"CD31	56	60	Gene_or_gene_product"	"PAS	65	68	Chemical"	"hypoxia inducible factor 1alpha	72	103	Gene_or_gene_product"	"HIF	106	109	Gene_or_gene_product"	"[{""token"": ""Tumor sections"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""endothelial cells"", ""start_span"": 33, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""CD31"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAS"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""hypoxia inducible factor 1alpha"", ""start_span"": 72, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"
Tumors greater than 35 mm3 treated with IR 24 hours previously or with TEMF had decreased blood vessels in the subcortex and more endothelial pseudopods projecting into hypoxic, HIF positive areas than tumors from the control group.	"Tumors	0	6	Cancer"	"blood vessels	90	103	Multi"	"subcortex	111	120	Cancer"	"endothelial pseudopods	130	152	Cellular_component"	"HIF	178	181	Gene_or_gene_product"	"tumors	202	208	Cancer"	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""blood vessels"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""subcortex"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""endothelial pseudopods"", ""start_span"": 130, ""end_span"": 152, ""type"": ""Cellular_component""}, {""token"": ""HIF"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Cancer""}]"
In the embryonic stem cells homozygous for these hypomorphic Apc alleles, the level of the APC protein was inversely correlated with both the beta - catenin accumulation and beta - catenin / T - cell factor transcriptional activity.	"embryonic stem cells	7	27	Cell"	"Apc	61	64	Gene_or_gene_product"	"APC	91	94	Gene_or_gene_product"	"beta - catenin	142	156	Gene_or_gene_product"	"beta - catenin	174	188	Gene_or_gene_product"	"T - cell factor	191	206	Gene_or_gene_product"	"[{""token"": ""embryonic stem cells"", ""start_span"": 7, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""Apc"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""APC"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 174, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""T - cell factor"", ""start_span"": 191, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}]"
Domain 5 ( D5) of cleaved high molecular weight kininogen ( HKa) inhibits angiogenesis in vivo and endothelial cell migration in vitro, but the cell signaling pathways involved in HKa and D5 inhibition of endothelial cell migration are incompletely delineated.	"high molecular weight kininogen	26	57	Gene_or_gene_product"	"HKa	60	63	Gene_or_gene_product"	"endothelial cell	99	115	Cell"	"cell	144	148	Cell"	"HKa	180	183	Gene_or_gene_product"	"endothelial cell	205	221	Cell"	"[{""token"": ""high molecular weight kininogen"", ""start_span"": 26, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""HKa"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""HKa"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 205, ""end_span"": 221, ""type"": ""Cell""}]"
Additional analysis of the mechanism of action of Go6976 ( RT - PCR, Western blots, and immunohistochemistry) of the changes in the phosphorylated and nonphosphorylated forms of PKCalpha in the cell membrane and cytoplasm confirmed the specificity of PKCalpha inhibition by Go6976.	"Go6976	50	56	Chemical"	"PKCalpha	178	186	Gene_or_gene_product"	"cell membrane	194	207	Cellular_component"	"cytoplasm	212	221	Organism_substance"	"PKCalpha	251	259	Gene_or_gene_product"	"Go6976	274	280	Chemical"	"[{""token"": ""Go6976"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""PKCalpha"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell membrane"", ""start_span"": 194, ""end_span"": 207, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 212, ""end_span"": 221, ""type"": ""Organism_substance""}, {""token"": ""PKCalpha"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""Go6976"", ""start_span"": 274, ""end_span"": 280, ""type"": ""Chemical""}]"
p63, a p53 homologue, is a myoepithelial cell marker in the normal mammary gland but p63 - positive neoplastic cells may be found in up to 11% of invasive breast carcinomas.	"p63	0	3	Gene_or_gene_product"	"p53	7	10	Gene_or_gene_product"	"myoepithelial cell	27	45	Cell"	"mammary gland	67	80	Organ"	"p63	85	88	Gene_or_gene_product"	"invasive breast carcinomas	146	172	Cancer"	"[{""token"": ""p63"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""myoepithelial cell"", ""start_span"": 27, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""mammary gland"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""p63"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""invasive breast carcinomas"", ""start_span"": 146, ""end_span"": 172, ""type"": ""Cancer""}]"
The transcription factor NF - kappaB and associated regulatory factors ( including IkappaB kinase subunits and the IkappaB family member Bcl - 3) are strongly implicated in a variety of hematologic and solid tumor malignancies.	"NF - kappaB	25	36	Gene_or_gene_product"	"IkappaB	83	90	Gene_or_gene_product"	"IkappaB	115	122	Gene_or_gene_product"	"Bcl - 3	137	144	Gene_or_gene_product"	"hematologic	186	197	Cancer"	"solid tumor malignancies	202	226	Cancer"	"[{""token"": ""NF - kappaB"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""IkappaB"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""IkappaB"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 3"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematologic"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Cancer""}, {""token"": ""solid tumor malignancies"", ""start_span"": 202, ""end_span"": 226, ""type"": ""Cancer""}]"
Thus, CECs, EPCs and EMPs may represent potentially novel methods for evaluating the vascular status of cancer patients.	"CECs	6	10	Cell"	"EPCs	12	16	Cell"	"EMPs	21	25	Cellular_component"	"vascular	85	93	Multi"	"cancer	104	110	Cancer"	"patients	111	119	Organism"	"[{""token"": ""CECs"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Cell""}, {""token"": ""EPCs"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""EMPs"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Cellular_component""}, {""token"": ""vascular"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Multi""}, {""token"": ""cancer"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Organism""}]"
We herein report the effects of novel developed material, collagen - poly glycolic acid fiber hybrid matrix, being used together with basic fibroblast growth factor to promote wound healing of full - thickness skin defects on the back of type 2 diabetic Lepr ( db) mice.	"collagen	58	66	Gene_or_gene_product"	"poly glycolic acid	69	87	Chemical"	"basic fibroblast growth factor	134	164	Gene_or_gene_product"	"wound	176	181	Pathological_formation"	"skin	210	214	Organ"	"Lepr	254	258	Gene_or_gene_product"	"[{""token"": ""collagen"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""poly glycolic acid"", ""start_span"": 69, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 134, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""wound"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Pathological_formation""}, {""token"": ""skin"", ""start_span"": 210, ""end_span"": 214, ""type"": ""Organ""}, {""token"": ""Lepr"", ""start_span"": 254, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}]"
The remaining wild - type Men1 allele was lost in most tumors from Men1 ( + / -) mice but was retained in most tumors from p18 ( - / -); Men1 ( + / -) mice.	"Men1	26	30	Gene_or_gene_product"	"tumors	55	61	Cancer"	"Men1	67	71	Gene_or_gene_product"	"tumors	111	117	Cancer"	"p18	123	126	Gene_or_gene_product"	"Men1	137	141	Gene_or_gene_product"	"[{""token"": ""Men1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""Men1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""p18"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"
The use of juice, peel and oil have also been shown to possess anticancer activities, including interference with tumor cell proliferation, cell cycle, invasion and angiogenesis.	"juice	11	16	Organism_substance"	"peel	18	22	Tissue"	"oil	27	30	Organism_substance"	"anticancer	63	73	Cancer"	"tumor cell	114	124	Cell"	"cell	140	144	Cell"	"[{""token"": ""juice"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Organism_substance""}, {""token"": ""peel"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Tissue""}, {""token"": ""oil"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Organism_substance""}, {""token"": ""anticancer"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 114, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Cell""}]"
The results revealed that the metastatic tumors in mouse lung were markedly decreased in a dose - dependent manner and acute lung injury induced by B16F10 melanoma metastasis was diminished by systemic rk - 2 treatment.	"tumors	41	47	Cancer"	"mouse	51	56	Organism"	"lung	57	61	Organ"	"lung	125	129	Organ"	"B16F10 melanoma	148	163	Cancer"	"rk - 2	202	208	Gene_or_gene_product"	"[{""token"": ""tumors"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Organ""}, {""token"": ""lung"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Organ""}, {""token"": ""B16F10 melanoma"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Cancer""}, {""token"": ""rk - 2"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}]"
Also, rk - 2 diminished the expression of matrix metalloproteinase - 2 and - 9 in the mouse lung which induces tumor metastasis and angiogenesis.	"rk - 2	6	12	Gene_or_gene_product"	"matrix metalloproteinase - 2	42	70	Gene_or_gene_product"	"- 9	75	78	Gene_or_gene_product"	"mouse	86	91	Organism"	"lung	92	96	Organ"	"tumor	111	116	Cancer"	"[{""token"": ""rk - 2"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 42, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Cancer""}]"
The 20 - HETE agonist markedly increased superoxide formation as reflected by an increase in dihydroethidium staining of EC, and this increase was inhibited by PEG - SOD but not by apocynin.	"20 - HETE	4	13	Chemical"	"superoxide	41	51	Chemical"	"dihydroethidium	93	108	Chemical"	"EC	121	123	Cell"	"PEG - SOD	160	169	Chemical"	"apocynin	181	189	Chemical"	"[{""token"": ""20 - HETE"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""superoxide"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""dihydroethidium"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""EC"", ""start_span"": 121, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""PEG - SOD"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Chemical""}, {""token"": ""apocynin"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Chemical""}]"
These data suggest that 20 - HETE stimulates superoxide formation by pathways other than apocynin - sensitive NAD ( P) H oxidase, thereby activating MAPK and then enhancing VEGF synthesis that drives EC proliferation.	"20 - HETE	24	33	Chemical"	"superoxide	45	55	Chemical"	"apocynin	89	97	Chemical"	"MAPK	149	153	Gene_or_gene_product"	"VEGF	173	177	Gene_or_gene_product"	"EC	200	202	Cell"	"[{""token"": ""20 - HETE"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""superoxide"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""apocynin"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""MAPK"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Cell""}]"
Cooperative activation of Meis1 and Hoxa9 perturbs myeloid differentiation and eventually leads myeloid progenitors to leukemia, yet it remains to be clarified what kinds of subsequent molecular processes are required for development of overt leukemia.	"Meis1	26	31	Gene_or_gene_product"	"Hoxa9	36	41	Gene_or_gene_product"	"myeloid	51	58	Cell"	"myeloid progenitors	96	115	Cell"	"leukemia	119	127	Cancer"	"overt leukemia	237	251	Cancer"	"[{""token"": ""Meis1"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hoxa9"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""myeloid progenitors"", ""start_span"": 96, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""leukemia"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""overt leukemia"", ""start_span"": 237, ""end_span"": 251, ""type"": ""Cancer""}]"
A greater accumulation of peroxidative products ( thiobarbituric acid - reactive substances), inflammation and decreased levels of GSH and total antioxidant reserves were also observed in the skin of DMBA - Cum - OOH - exposed mice.	"thiobarbituric acid	50	69	Chemical"	"GSH	131	134	Chemical"	"skin	192	196	Organ"	"DMBA	200	204	Chemical"	"Cum - OOH	207	216	Chemical"	"mice	227	231	Organism"	"[{""token"": ""thiobarbituric acid"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""skin"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Organ""}, {""token"": ""DMBA"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 207, ""end_span"": 216, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Organism""}]"
v - Src morphologically transformed MEFs lacking SWAP - 70, but growth of the transformed cells in culture was slower than that of cells supplemented with exogenous SWAP - 70.	"v - Src	0	7	Gene_or_gene_product"	"MEFs	36	40	Cell"	"SWAP - 70	49	58	Gene_or_gene_product"	"cells	90	95	Cell"	"cells	131	136	Cell"	"SWAP - 70	165	174	Gene_or_gene_product"	"[{""token"": ""v - Src"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"
When transplanted in nude mice, tumors formed by the v - Src transformed SWAP - 70 ( - / -) MEFs were smaller than those formed by cells expressing exogenous SWAP - 70.	"nude mice	21	30	Organism"	"tumors	32	38	Cancer"	"v - Src	53	60	Gene_or_gene_product"	"SWAP - 70	73	82	Gene_or_gene_product"	"cells	131	136	Cell"	"SWAP - 70	158	167	Gene_or_gene_product"	"[{""token"": ""nude mice"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""v - Src"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""SWAP - 70"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"
Previous studies reported that the Tumor Susceptibility Gene 101 ( TSG101) is upregulated in selected human malignancies, and the expression of exogenous Tsg101 was suggested to transform immortalized fibroblasts in culture.	"Tumor Susceptibility Gene 101	35	64	Gene_or_gene_product"	"TSG101	67	73	Gene_or_gene_product"	"human	102	107	Organism"	"malignancies	108	120	Cancer"	"Tsg101	154	160	Gene_or_gene_product"	"fibroblasts	201	212	Cell"	"[{""token"": ""Tumor Susceptibility Gene 101"", ""start_span"": 35, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSG101"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""malignancies"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""Tsg101"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Cell""}]"
Expression of Bcl - xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.	"Bcl - xL	14	22	Gene_or_gene_product"	"Bax	24	27	Gene_or_gene_product"	"p53	33	36	Gene_or_gene_product"	"primary tumors	40	54	Cancer"	"lymph node	59	69	Multi"	"oral squamous cell carcinoma	84	112	Cancer"	"[{""token"": ""Bcl - xL"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary tumors"", ""start_span"": 40, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 84, ""end_span"": 112, ""type"": ""Cancer""}]"
Platelet - derived growth factor ( PDGF) and its receptors ( PDGFR) play important roles in tumorigenesis through stimulating tumor growth and promoting angiogenesis via enhancing pericyte recruitment and vessel maturation.	"Platelet - derived growth factor	0	32	Gene_or_gene_product"	"PDGF	35	39	Gene_or_gene_product"	"PDGFR	61	66	Gene_or_gene_product"	"tumor	92	97	Cancer"	"pericyte	180	188	Cell"	"vessel	205	211	Multi"	"[{""token"": ""Platelet - derived growth factor"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGF"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGFR"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""pericyte"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Multi""}]"
In this study, we investigated the effects of caffeine on HIF - 1 protein accumulation and on VEGF and IL - 8 expression in the human colon cancer cell line HT29 under hypoxic conditions.	"caffeine	46	54	Chemical"	"HIF - 1	58	65	Gene_or_gene_product"	"VEGF	94	98	Gene_or_gene_product"	"IL - 8	103	109	Gene_or_gene_product"	"human	128	133	Organism"	"colon cancer cell line HT29	134	161	Cell"	"[{""token"": ""caffeine"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""HIF - 1"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""colon cancer cell line HT29"", ""start_span"": 134, ""end_span"": 161, ""type"": ""Cell""}]"
Pretreatment of cells with caffeine significantly reduces adenosine - induced VEGF promoter activity and VEGF and IL - 8 expression.	"cells	16	21	Cell"	"caffeine	27	35	Chemical"	"adenosine	58	67	Chemical"	"VEGF	78	82	Gene_or_gene_product"	"VEGF	105	109	Gene_or_gene_product"	"IL - 8	114	120	Gene_or_gene_product"	"[{""token"": ""cells"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""caffeine"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""adenosine"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"
The metastatic potentials of several human prostate cancer xenograft models, LAPC - 4, LAPC - 9, PC3 and CWR22Rv - 1 were compared.	"human	37	42	Organism"	"prostate cancer xenograft	43	68	Cancer"	"LAPC - 4	77	85	Cell"	"LAPC - 9	87	95	Cell"	"PC3	97	100	Cell"	"CWR22Rv - 1	105	116	Cell"	"[{""token"": ""human"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""prostate cancer xenograft"", ""start_span"": 43, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""LAPC - 4"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""LAPC - 9"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""PC3"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""CWR22Rv - 1"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Cell""}]"
The effect of taxol, cobalt chloride and a heparin - steroid combination was tested in the fat tissue assay and compared to the validated human placental vein angiogenesis model ( HPVAM).	"taxol	14	19	Chemical"	"cobalt chloride	21	36	Chemical"	"heparin - steroid	43	60	Chemical"	"fat tissue	91	101	Tissue"	"human	138	143	Organism"	"placental vein	144	158	Multi"	"[{""token"": ""taxol"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""cobalt chloride"", ""start_span"": 21, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""heparin - steroid"", ""start_span"": 43, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""fat tissue"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""placental vein"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Multi""}]"
Cobalt chloride, a stimulator of vascular endothelial growth factor ( VEGF) stimulated angiogenesis initiation at 10 ( - 9) M in fat tissue and the HPVAM, but at 10 ( - 10) M blood vessel growth was stimulated only in the fat assay.	"Cobalt chloride	0	15	Chemical"	"vascular endothelial growth factor	33	67	Gene_or_gene_product"	"VEGF	70	74	Gene_or_gene_product"	"fat tissue	129	139	Tissue"	"blood vessel	175	187	Multi"	"fat	222	225	Tissue"	"[{""token"": ""Cobalt chloride"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 33, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""fat tissue"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Tissue""}, {""token"": ""blood vessel"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Multi""}, {""token"": ""fat"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Tissue""}]"
BAG - 1 is expressed ubiquitously in human cells as three major isoforms of 50 kDa ( BAG - 1L), 46 kDa ( BAG - 1M) and 36 kDa ( BAG - 1S) from a single mRNA.	"BAG - 1	0	7	Gene_or_gene_product"	"human	37	42	Organism"	"cells	43	48	Cell"	"BAG - 1L	85	93	Gene_or_gene_product"	"BAG - 1M	105	113	Gene_or_gene_product"	"BAG - 1S	128	136	Gene_or_gene_product"	"[{""token"": ""BAG - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""BAG - 1L"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1M"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1S"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"
The breast epithelium comprises cells at different stages of differentiation, including stem cells, progenitor cells, and more differentiated epithelial and myoepithelial cells.	"breast epithelium	4	21	Tissue"	"cells	32	37	Cell"	"stem cells	88	98	Cell"	"progenitor cells	100	116	Cell"	"epithelial	142	152	Cell"	"myoepithelial cells	157	176	Cell"	"[{""token"": ""breast epithelium"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Tissue""}, {""token"": ""cells"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""stem cells"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""epithelial"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Cell""}, {""token"": ""myoepithelial cells"", ""start_span"": 157, ""end_span"": 176, ""type"": ""Cell""}]"
Among 18 BCR - ABL + leukemias presenting acquired trisomy of chromosome 21, we report a high frequency ( 33%) of recurrent point mutations ( 4 in myeloid blast crisis [ BC] CML and one in chronic phase CML) within the DNA - binding region of RUNX1.	"BCR	9	12	Gene_or_gene_product"	"ABL	15	18	Gene_or_gene_product"	"chromosome 21	62	75	Cellular_component"	"chronic phase CML	189	206	Cancer"	"DNA	219	222	Cellular_component"	"RUNX1	243	248	Gene_or_gene_product"	"[{""token"": ""BCR"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome 21"", ""start_span"": 62, ""end_span"": 75, ""type"": ""Cellular_component""}, {""token"": ""chronic phase CML"", ""start_span"": 189, ""end_span"": 206, ""type"": ""Cancer""}, {""token"": ""DNA"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}]"
These events are associated with a short survival and support the concept of a cooperative effect of BCR - ABL with molecular RUNX1 abnormalities on the differentiation arrest phenotype observed during progression of CML and in BCR - ABL + ALL.	"BCR	101	104	Gene_or_gene_product"	"ABL	107	110	Gene_or_gene_product"	"RUNX1	126	131	Gene_or_gene_product"	"CML	217	220	Cancer"	"BCR	228	231	Gene_or_gene_product"	"ABL	234	237	Gene_or_gene_product"	"[{""token"": ""BCR"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""RUNX1"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Cancer""}, {""token"": ""BCR"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"
In this study, we determined the effectiveness of vasostatin delivered by recombinant pseudotype adeno - associated virus 2 / 5 ( rAAV2 / 5 - VAS) as a gene therapy approach for lung cancer treatment.	"vasostatin	50	60	Gene_or_gene_product"	"recombinant pseudotype adeno - associated virus 2	74	123	Organism"	"5	126	127	Organism"	"rAAV2	130	135	Organism"	"5 - VAS	138	145	Organism"	"lung cancer	178	189	Cancer"	"[{""token"": ""vasostatin"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""recombinant pseudotype adeno - associated virus 2"", ""start_span"": 74, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""5"", ""start_span"": 126, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""rAAV2"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Organism""}, {""token"": ""lung cancer"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Cancer""}]"
In the orthotopic xenograft model, rAAV2 / 5 - VAS suppressed metastasis of A549 tumors to mediastinal lymph nodes and contralateral lung.	"xenograft	18	27	Cancer"	"rAAV2	35	40	Organism"	"5 - VAS	43	50	Organism"	"A549 tumors	76	87	Cancer"	"lymph nodes	103	114	Multi"	"lung	133	137	Organ"	"[{""token"": ""xenograft"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""A549 tumors"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Multi""}, {""token"": ""lung"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Organ""}]"
The UFO proto - oncogene maps to human chromosome 19q13. 1 and is transcribed into two 5. 0 kb and 3. 2 kb mRNAs in human bone marrow and human tumor cell lines.	"UFO	4	7	Gene_or_gene_product"	"human	33	38	Organism"	"human	116	121	Organism"	"bone marrow	122	133	Multi"	"human	138	143	Organism"	"tumor cell lines	144	160	Cell"	"[{""token"": ""UFO"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""bone marrow"", ""start_span"": 122, ""end_span"": 133, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""tumor cell lines"", ""start_span"": 144, ""end_span"": 160, ""type"": ""Cell""}]"
After confirming the results in agar - processed cell lines, annexin II and beta ( 2) - tubulin expression were found to be lower in tumor cells than in adjacent normal epithelial cells in 100% and 90% of the patients ' specimens, respectively.	"cell lines	49	59	Cell"	"annexin II	61	71	Gene_or_gene_product"	"tumor cells	133	144	Cell"	"normal epithelial cells	162	185	Cell"	"patients	209	217	Organism"	"specimens	220	229	Cell"	"[{""token"": ""cell lines"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""annexin II"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""normal epithelial cells"", ""start_span"": 162, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Organism""}, {""token"": ""specimens"", ""start_span"": 220, ""end_span"": 229, ""type"": ""Cell""}]"
MMTV - cre - mediated fur inactivation concomitant with PLAG1 proto - oncogene activation delays salivary gland tumorigenesis in mice.	"MMTV	0	4	Organism"	"cre	7	10	Gene_or_gene_product"	"fur	22	25	Gene_or_gene_product"	"PLAG1	56	61	Gene_or_gene_product"	"salivary gland	97	111	Multi"	"mice	129	133	Organism"	"[{""token"": ""MMTV"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""cre"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""fur"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLAG1"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""salivary gland"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Organism""}]"
Tumor cells express the glycolytic regulator pyruvate kinase subtype M2 ( M2 - PK), which can occur in a tetrameric form with high affinity to its substrate phosphoenolpyruvate ( PEP) and a dimeric form with a low PEP affinity.	"Tumor cells	0	11	Cell"	"pyruvate kinase subtype M2	45	71	Gene_or_gene_product"	"M2 - PK	74	81	Gene_or_gene_product"	"phosphoenolpyruvate	157	176	Chemical"	"PEP	179	182	Chemical"	"PEP	214	217	Chemical"	"[{""token"": ""Tumor cells"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""pyruvate kinase subtype M2"", ""start_span"": 45, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""M2 - PK"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoenolpyruvate"", ""start_span"": 157, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""PEP"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""PEP"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Chemical""}]"
Atypically, abundant capillaries were observed; however, the cystic proliferation of epithelioid cells with vacuoles and immunohistochemical profile of the epithelioid element were consistent with hepatic adenomatoid tumour.	"capillaries	21	32	Tissue"	"cystic	61	67	Pathological_formation"	"epithelioid cells	85	102	Cell"	"vacuoles	108	116	Cellular_component"	"epithelioid element	156	175	Tissue"	"hepatic adenomatoid tumour	197	223	Cancer"	"[{""token"": ""capillaries"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Tissue""}, {""token"": ""cystic"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Pathological_formation""}, {""token"": ""epithelioid cells"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Cell""}, {""token"": ""vacuoles"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Cellular_component""}, {""token"": ""epithelioid element"", ""start_span"": 156, ""end_span"": 175, ""type"": ""Tissue""}, {""token"": ""hepatic adenomatoid tumour"", ""start_span"": 197, ""end_span"": 223, ""type"": ""Cancer""}]"
Comparisons of presymposium and postsymposium responses and between the 2 groups of attendees indicated that the pediatric dentistry and endodontic communities agree that formocresol will be replaced as a primary tooth pulpotomy agent, that mineral trioxide is the first choice to take its place, that IPT in primary teeth holds hope as a replacement for pulpotomy, and that IPT is an acceptable pulp therapy technique for cariously involved young permanent teeth.	"formocresol	171	182	Chemical"	"tooth	213	218	Organ"	"mineral trioxide	241	257	Chemical"	"teeth	317	322	Organ"	"pulp	355	359	Tissue"	"teeth	458	463	Organ"	"[{""token"": ""formocresol"", ""start_span"": 171, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""tooth"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Organ""}, {""token"": ""mineral trioxide"", ""start_span"": 241, ""end_span"": 257, ""type"": ""Chemical""}, {""token"": ""teeth"", ""start_span"": 317, ""end_span"": 322, ""type"": ""Organ""}, {""token"": ""pulp"", ""start_span"": 355, ""end_span"": 359, ""type"": ""Tissue""}, {""token"": ""teeth"", ""start_span"": 458, ""end_span"": 463, ""type"": ""Organ""}]"
Similar to in vivo FdG - PET or primary breast cancers, rates of glycolysis were diverse, being higher in cells expressing both c - Myc and HIF - 1alpha and lower in cell lines low or negative in both transcription factors.	"FdG	19	22	Chemical"	"primary breast cancers	32	54	Cancer"	"cells	106	111	Cell"	"c - Myc	128	135	Gene_or_gene_product"	"HIF - 1alpha	140	152	Gene_or_gene_product"	"cell lines	166	176	Cell"	"[{""token"": ""FdG"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""primary breast cancers"", ""start_span"": 32, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""c - Myc"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 140, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Cell""}]"
The grafts are extensively vascularized with capillaries composed of nonfenestrated endothelium; intercellular junctions are evident at sites of apposition between endothelial cells.	"grafts	4	10	Tissue"	"capillaries	45	56	Tissue"	"endothelium	84	95	Tissue"	"intercellular junctions	97	120	Cellular_component"	"sites of apposition	136	155	Cellular_component"	"endothelial cells	164	181	Cell"	"[{""token"": ""grafts"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Tissue""}, {""token"": ""capillaries"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Tissue""}, {""token"": ""endothelium"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""intercellular junctions"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Cellular_component""}, {""token"": ""sites of apposition"", ""start_span"": 136, ""end_span"": 155, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 164, ""end_span"": 181, ""type"": ""Cell""}]"
Using a construct containing the VEGF promoter linked to a luciferase reporter, we found that a mutation reducing HIF binding to the VEGF promoter had no significant effect on luciferase production induced by M - CSF stimulation.	"VEGF	33	37	Gene_or_gene_product"	"luciferase	59	69	Gene_or_gene_product"	"HIF	114	117	Gene_or_gene_product"	"VEGF	133	137	Gene_or_gene_product"	"luciferase	176	186	Gene_or_gene_product"	"M - CSF	209	216	Gene_or_gene_product"	"[{""token"": ""VEGF"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 176, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene_or_gene_product""}]"
CONCLUSION: These data delineate an ERK - and Sp1 - dependent mechanism of M - CSF induced VEGF production and demonstrate for the first time the ability of M - CSF to induce angiogenesis via VEGF in vivo.	"ERK	36	39	Gene_or_gene_product"	"Sp1	46	49	Gene_or_gene_product"	"M - CSF	75	82	Gene_or_gene_product"	"VEGF	91	95	Gene_or_gene_product"	"M - CSF	157	164	Gene_or_gene_product"	"VEGF	192	196	Gene_or_gene_product"	"[{""token"": ""ERK"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sp1"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}]"
PI3K / Akt - dependent transcriptional regulation and activation of BMP - 2 - Smad signaling by NF - kappaB in metastatic prostate cancer cells.	"PI3K	0	4	Gene_or_gene_product"	"Akt	7	10	Gene_or_gene_product"	"BMP - 2	68	75	Gene_or_gene_product"	"Smad	78	82	Gene_or_gene_product"	"NF - kappaB	96	107	Gene_or_gene_product"	"prostate cancer cells	122	143	Cell"	"[{""token"": ""PI3K"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer cells"", ""start_span"": 122, ""end_span"": 143, ""type"": ""Cell""}]"
In the presence of high levels of VEGF, Ang - 2 also promotes rapid increase in capillary diameter, remodeling of the basal lamina, proliferation and migration of endothelial cells, and stimulates sprouting of new blood vessels.	"VEGF	34	38	Gene_or_gene_product"	"Ang - 2	40	47	Gene_or_gene_product"	"capillary	80	89	Tissue"	"basal lamina	118	130	Cellular_component"	"endothelial cells	163	180	Cell"	"blood vessels	214	227	Multi"	"[{""token"": ""VEGF"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang - 2"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""basal lamina"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 163, ""end_span"": 180, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 214, ""end_span"": 227, ""type"": ""Multi""}]"
The heart functions ( left ventricle ejection fraction ( LVEF), left ventricle fractional shortening ( LVFS)) were improved more significantly in the old donor - derived MSCs group than in the control group and the heart function in the young donor - derived MSCs group further improved ( P less than 0. 05).	"heart	4	9	Organ"	"ventricle	27	36	Multi"	"ventricle	69	78	Multi"	"MSCs	170	174	Cell"	"heart	215	220	Organ"	"MSCs	259	263	Cell"	"[{""token"": ""heart"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organ""}, {""token"": ""ventricle"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""ventricle"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Multi""}, {""token"": ""MSCs"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""heart"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Organ""}, {""token"": ""MSCs"", ""start_span"": 259, ""end_span"": 263, ""type"": ""Cell""}]"
We investigated the presence of COUP - TFII in human colorectal cancer tissues and adjacent normal tissues from 95 primary colorectal cancer patients by immunohistochemistry.	"COUP - TFII	32	43	Gene_or_gene_product"	"human	47	52	Organism"	"colorectal cancer tissues	53	78	Tissue"	"normal tissues	92	106	Tissue"	"colorectal cancer	123	140	Cancer"	"patients	141	149	Organism"	"[{""token"": ""COUP - TFII"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""colorectal cancer tissues"", ""start_span"": 53, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""normal tissues"", ""start_span"": 92, ""end_span"": 106, ""type"": ""Tissue""}, {""token"": ""colorectal cancer"", ""start_span"": 123, ""end_span"": 140, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Organism""}]"
Downstream targets of Plexin C1 signaling in human melanocytes include cofilin and LIM kinase II, both of which are critical mediators of cell adhesion and migration.	"Plexin C1	22	31	Gene_or_gene_product"	"human	45	50	Organism"	"melanocytes	51	62	Cell"	"cofilin	71	78	Gene_or_gene_product"	"LIM kinase II	83	96	Gene_or_gene_product"	"cell	138	142	Cell"	"[{""token"": ""Plexin C1"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""melanocytes"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""cofilin"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""LIM kinase II"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Cell""}]"
Our data show a significant loss of Plexin C1 in metastatic melanoma compared with primary melanoma, suggesting the possibility that the Plexin C1 receptor is a tumor suppressor protein for melanoma.	"Plexin C1	36	45	Gene_or_gene_product"	"metastatic melanoma	49	68	Cancer"	"primary melanoma	83	99	Cancer"	"Plexin C1	137	146	Gene_or_gene_product"	"tumor	161	166	Cancer"	"melanoma	190	198	Cancer"	"[{""token"": ""Plexin C1"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastatic melanoma"", ""start_span"": 49, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""primary melanoma"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""Plexin C1"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Cancer""}, {""token"": ""melanoma"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Cancer""}]"
FOXO3a elicits a pro - apoptotic transcription program and cellular response to human lung carcinogen nicotine - derived nitrosaminoketone ( NNK).	"FOXO3a	0	6	Gene_or_gene_product"	"cellular	59	67	Cell"	"human	80	85	Organism"	"lung	86	90	Organ"	"nicotine - derived nitrosaminoketone	102	138	Chemical"	"NNK	141	144	Chemical"	"[{""token"": ""FOXO3a"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Organ""}, {""token"": ""nicotine - derived nitrosaminoketone"", ""start_span"": 102, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""NNK"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Chemical""}]"
Inhibition of the UV - induced activation of Erbb2 also resulted in milder epidermal hyperplasia, S - phase accumulation, and decreased levels of the cell cycle regulator Cdc25a, suggesting altered cell cycle regulation on inhibition of Erbb2.	"Erbb2	45	50	Gene_or_gene_product"	"epidermal hyperplasia	75	96	Pathological_formation"	"cell	150	154	Cell"	"Cdc25a	171	177	Gene_or_gene_product"	"cell	198	202	Cell"	"Erbb2	237	242	Gene_or_gene_product"	"[{""token"": ""Erbb2"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal hyperplasia"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Pathological_formation""}, {""token"": ""cell"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Cell""}, {""token"": ""Cdc25a"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Cell""}, {""token"": ""Erbb2"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}]"
Ectopic expression of Cdc25a prevented UV - induced S - phase arrest in keratinocytes lacking Erbb2 activity, demonstrating that maintenance of Cdc25a by Erbb2 suppresses cell cycle arrest.	"Cdc25a	22	28	Gene_or_gene_product"	"keratinocytes	72	85	Cell"	"Erbb2	94	99	Gene_or_gene_product"	"Cdc25a	144	150	Gene_or_gene_product"	"Erbb2	154	159	Gene_or_gene_product"	"cell	171	175	Cell"	"[{""token"": ""Cdc25a"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratinocytes"", ""start_span"": 72, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""Erbb2"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc25a"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erbb2"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Cell""}]"
Thus, UV - induced Erbb2 activation increases skin tumorigenesis through inhibitory phosphorylation of Chk1, Cdc25a maintenance, and suppression of S - phase arrest via a PI3K / Akt - dependent mechanism.	"Erbb2	19	24	Gene_or_gene_product"	"skin	46	50	Organ"	"Chk1	103	107	Gene_or_gene_product"	"Cdc25a	109	115	Gene_or_gene_product"	"PI3K	171	175	Gene_or_gene_product"	"Akt	178	181	Gene_or_gene_product"	"[{""token"": ""Erbb2"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Organ""}, {""token"": ""Chk1"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc25a"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}]"
Pathological analyses indicate that a significant large population of human ductal cancers may utilize the EGFR - GEP100 - Arf6 - AMAP1 pathway for their malignancy.	"human	70	75	Organism"	"ductal cancers	76	90	Cancer"	"EGFR	107	111	Gene_or_gene_product"	"GEP100	114	120	Gene_or_gene_product"	"Arf6	123	127	Gene_or_gene_product"	"AMAP1	130	135	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism""}, {""token"": ""ductal cancers"", ""start_span"": 76, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""EGFR"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""GEP100"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf6"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMAP1"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"
We used a cellular model of tumor invasion to investigate the effect of activated platelets on the human ovarian cancer cell line, SKOV3.	"cellular	10	18	Cell"	"tumor	28	33	Cancer"	"platelets	82	91	Cell"	"human	99	104	Organism"	"ovarian cancer cell line	105	129	Cell"	"SKOV3	131	136	Cell"	"[{""token"": ""cellular"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""platelets"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organism""}, {""token"": ""ovarian cancer cell line"", ""start_span"": 105, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""SKOV3"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cell""}]"
SKOV3 cells were exposed to washed, thrombin receptor activating peptide ( TRAP) - activated or TRAP - naive platelets under various experimental conditions, and tumor cell invasion was assayed in Matrigel chambers.	"SKOV3 cells	0	11	Cell"	"thrombin receptor activating peptide	36	72	Gene_or_gene_product"	"TRAP	75	79	Gene_or_gene_product"	"TRAP	96	100	Gene_or_gene_product"	"platelets	109	118	Cell"	"tumor cell	162	172	Cell"	"[{""token"": ""SKOV3 cells"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""thrombin receptor activating peptide"", ""start_span"": 36, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAP"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAP"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelets"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Cell""}]"
A further study found that FGFR2 - positive fibroblasts were only observed inside the tumor tissues and not in tumor - surrounding stromal tissues, suggesting that FGFR2 could be used as a TF - specific marker in ESCC.	"FGFR2	27	32	Gene_or_gene_product"	"tumor tissues	86	99	Tissue"	"tumor - surrounding stromal tissues	111	146	Tissue"	"FGFR2	164	169	Gene_or_gene_product"	"TF	189	191	Cell"	"ESCC	213	217	Cancer"	"[{""token"": ""FGFR2"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor tissues"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Tissue""}, {""token"": ""tumor - surrounding stromal tissues"", ""start_span"": 111, ""end_span"": 146, ""type"": ""Tissue""}, {""token"": ""FGFR2"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Cell""}, {""token"": ""ESCC"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Cancer""}]"
FA induced GR - mediated transcription in Ca3 / 7 cells transfected with a luciferase reporter gene under the control of glucocorticoid response element ( GRE), but DMI alone did not affect GR - mediated transcription.	"FA	0	2	Chemical"	"GR	11	13	Gene_or_gene_product"	"Ca3 / 7 cells	42	55	Cell"	"luciferase reporter gene	75	99	Gene_or_gene_product"	"DMI	165	168	Chemical"	"GR	190	192	Gene_or_gene_product"	"[{""token"": ""FA"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ca3 / 7 cells"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""luciferase reporter gene"", ""start_span"": 75, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""DMI"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 190, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"
In a xenograft model metronomic CPT - 11, but not 5 - FU and L - OHP, significantly inhibits HT - 29 tumor growth and microvessel density in the absence of toxicity.	"xenograft	5	14	Cancer"	"CPT - 11	32	40	Chemical"	"5 - FU	50	56	Chemical"	"L - OHP	61	68	Chemical"	"HT - 29 tumor	93	106	Cancer"	"microvessel	118	129	Tissue"	"[{""token"": ""xenograft"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""CPT - 11"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""HT - 29 tumor"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Tissue""}]"
All genes except those encoding angiotensinogen and epoxide hydrolase ( that were decreased), and 12 - lipoxygenase and vascular endothelial growth factor ( that showed no change), were significantly up - regulated in GK islets.	"angiotensinogen	32	47	Gene_or_gene_product"	"epoxide hydrolase	52	69	Gene_or_gene_product"	"12 - lipoxygenase	98	115	Gene_or_gene_product"	"vascular endothelial growth factor	120	154	Gene_or_gene_product"	"GK	218	220	Organism"	"islets	221	227	Multi"	"[{""token"": ""angiotensinogen"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""epoxide hydrolase"", ""start_span"": 52, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""12 - lipoxygenase"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 120, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""GK"", ""start_span"": 218, ""end_span"": 220, ""type"": ""Organism""}, {""token"": ""islets"", ""start_span"": 221, ""end_span"": 227, ""type"": ""Multi""}]"
From these data, as well as earlier evidence demonstrating that the reduced nicotinamide adenine dinucleotide ( NADH) shuttle in these cells requires a transaminase step and is thus identified as the malate - aspartate shuttle ( W. V. V. Greenhouse and A. L. Lehninger, Cancer Res., 36: 1392 - 1396, 1976), metabolic flux diagrams were constructed for the five cell lines.	"nicotinamide adenine dinucleotide	76	109	Chemical"	"NADH	112	116	Chemical"	"cells	135	140	Cell"	"malate	200	206	Chemical"	"aspartate	209	218	Chemical"	"cell lines	361	371	Cell"	"[{""token"": ""nicotinamide adenine dinucleotide"", ""start_span"": 76, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""NADH"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""malate"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Chemical""}, {""token"": ""cell lines"", ""start_span"": 361, ""end_span"": 371, ""type"": ""Cell""}]"
In parallel, we assessed several human melanoma biopsy samples and found again that AKT2 was the predominantly activated AKT in these human melanoma biopsies.	"human	33	38	Organism"	"melanoma biopsy samples	39	62	Tissue"	"AKT2	84	88	Gene_or_gene_product"	"AKT	121	124	Gene_or_gene_product"	"human	134	139	Organism"	"melanoma biopsies	140	157	Tissue"	"[{""token"": ""human"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""melanoma biopsy samples"", ""start_span"": 39, ""end_span"": 62, ""type"": ""Tissue""}, {""token"": ""AKT2"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Organism""}, {""token"": ""melanoma biopsies"", ""start_span"": 140, ""end_span"": 157, ""type"": ""Tissue""}]"
In addition, a reduction in tumor volume of Grm1 - mouse - melanocytic - allografts was detected in the presence of small interfering AKT2 RNA ( siAKT2).	"tumor	28	33	Cancer"	"Grm1	44	48	Gene_or_gene_product"	"mouse	51	56	Organism"	"melanocytic - allografts	59	83	Tissue"	"AKT2	134	138	Gene_or_gene_product"	"siAKT2	145	151	Gene_or_gene_product"	"[{""token"": ""tumor"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""Grm1"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""melanocytic - allografts"", ""start_span"": 59, ""end_span"": 83, ""type"": ""Tissue""}, {""token"": ""AKT2"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""siAKT2"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"
A significantly reduced expression of SEMA3B ( 83 kDa), SEMA3F ( 90 kDa), and plexin - A3 was observed in ovarian cancer cell lines when compared with normal human ovarian surface epithelial cells.	"SEMA3B	38	44	Gene_or_gene_product"	"SEMA3F	56	62	Gene_or_gene_product"	"plexin - A3	78	89	Gene_or_gene_product"	"ovarian cancer cell lines	106	131	Cell"	"human	158	163	Organism"	"ovarian surface epithelial cells	164	196	Cell"	"[{""token"": ""SEMA3B"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""plexin - A3"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cell lines"", ""start_span"": 106, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organism""}, {""token"": ""ovarian surface epithelial cells"", ""start_span"": 164, ""end_span"": 196, ""type"": ""Cell""}]"
The expression of NP - 1, NP - 2, and plexin - A1 was not altered in human ovarian surface epithelial and ovarian cancer cells.	"NP - 1	18	24	Gene_or_gene_product"	"NP - 2	26	32	Gene_or_gene_product"	"plexin - A1	38	49	Gene_or_gene_product"	"human	69	74	Organism"	"ovarian surface epithelial	75	101	Cell"	"ovarian cancer cells	106	126	Cell"	"[{""token"": ""NP - 1"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""NP - 2"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""plexin - A1"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""ovarian surface epithelial"", ""start_span"": 75, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""ovarian cancer cells"", ""start_span"": 106, ""end_span"": 126, ""type"": ""Cell""}]"
Overexpression of SEMA3B and SEMA3F reduced focal adhesion kinase phosphorylation and matrix metalloproteinase - 2 and matrix metalloproteinase - 9 expression in ovarian cancer cells.	"SEMA3B	18	24	Gene_or_gene_product"	"SEMA3F	29	35	Gene_or_gene_product"	"focal adhesion kinase	44	65	Gene_or_gene_product"	"matrix metalloproteinase - 2	86	114	Gene_or_gene_product"	"matrix metalloproteinase - 9	119	147	Gene_or_gene_product"	"ovarian cancer cells	162	182	Cell"	"[{""token"": ""SEMA3B"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesion kinase"", ""start_span"": 44, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 86, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 119, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Cell""}]"
Here we demonstrate that repetitive exposure to tobacco smoke promotes tumor development both in carcinogen - treated mice and in transgenic mice undergoing sporadic K - ras activation in lung epithelial cells.	"tobacco	48	55	Organism"	"tumor	71	76	Cancer"	"mice	118	122	Organism"	"mice	141	145	Organism"	"K - ras	166	173	Gene_or_gene_product"	"lung epithelial cells	188	209	Cell"	"[{""token"": ""tobacco"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung epithelial cells"", ""start_span"": 188, ""end_span"": 209, ""type"": ""Cell""}]"
Tumor promotion is due to induction of inflammation that results in enhanced pneumocyte proliferation and is abrogated by IKKbeta ablation in myeloid cells or inactivation of JNK1.	"Tumor	0	5	Cancer"	"inflammation	39	51	Pathological_formation"	"pneumocyte	77	87	Cell"	"IKKbeta	122	129	Gene_or_gene_product"	"myeloid cells	142	155	Cell"	"JNK1	175	179	Gene_or_gene_product"	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""inflammation"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Pathological_formation""}, {""token"": ""pneumocyte"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""IKKbeta"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid cells"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""JNK1"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"
Unlike the majority of somatic cells, in which hTERT and telomerase activity are generally silent, normal lymphocytes show transient physiological hTERT expression and telomerase activity according to their differentiation / activation status.	"somatic cells	23	36	Cell"	"hTERT	47	52	Gene_or_gene_product"	"telomerase	57	67	Gene_or_gene_product"	"lymphocytes	106	117	Cell"	"hTERT	147	152	Gene_or_gene_product"	"telomerase	168	178	Gene_or_gene_product"	"[{""token"": ""somatic cells"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""hTERT"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphocytes"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""hTERT"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"
The results showed that betulin significantly inhibited cell viability in cervix carcinoma HeLa cells, hepatoma HepG2 cells, lung adenocarcinoma A549 cells, and breast cancer MCF - 7 cells with IC ( 50) values ranging from 10 to 15 microg / mL.	"betulin	24	31	Chemical"	"cell	56	60	Cell"	"cervix carcinoma HeLa cells	74	101	Cell"	"hepatoma HepG2 cells	103	123	Cell"	"lung adenocarcinoma A549 cells	125	155	Cell"	"breast cancer MCF - 7 cells	161	188	Cell"	"[{""token"": ""betulin"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""cervix carcinoma HeLa cells"", ""start_span"": 74, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""hepatoma HepG2 cells"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""lung adenocarcinoma A549 cells"", ""start_span"": 125, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""breast cancer MCF - 7 cells"", ""start_span"": 161, ""end_span"": 188, ""type"": ""Cell""}]"
Betulin ( 10 microg / mL) induces apoptotic cell death, as evidenced by morphological characteristics such as membrane phosphatidylserine translocation, nuclear condensation / fragmentation, and apoptotic body formation.	"Betulin	0	7	Chemical"	"cell	44	48	Cell"	"membrane	110	118	Cellular_component"	"phosphatidylserine	119	137	Amino_acid"	"nuclear	153	160	Cellular_component"	"apoptotic body	195	209	Cellular_component"	"[{""token"": ""Betulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Cellular_component""}, {""token"": ""phosphatidylserine"", ""start_span"": 119, ""end_span"": 137, ""type"": ""Amino_acid""}, {""token"": ""nuclear"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Cellular_component""}, {""token"": ""apoptotic body"", ""start_span"": 195, ""end_span"": 209, ""type"": ""Cellular_component""}]"
SAHA enhanced acetylation of histone H3 in Bim promoter region, while E1A upregulated Egr - 1, which was directly involved in Bim transactivation.	"SAHA	0	4	Chemical"	"histone H3	29	39	Gene_or_gene_product"	"Bim	43	46	Gene_or_gene_product"	"E1A	70	73	Gene_or_gene_product"	"Egr - 1	86	93	Gene_or_gene_product"	"Bim	126	129	Gene_or_gene_product"	"[{""token"": ""SAHA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""histone H3"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bim"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""Egr - 1"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bim"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"
Brick1 ( Brk1) is the less - studied component of the Wave / Scar pathway involved in the branched nucleation of actin fibers.	"Brick1	0	6	Gene_or_gene_product"	"Brk1	9	13	Gene_or_gene_product"	"Wave	54	58	Gene_or_gene_product"	"Scar	61	65	Gene_or_gene_product"	"actin	113	118	Gene_or_gene_product"	"fibers	119	125	Cellular_component"	"[{""token"": ""Brick1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""Brk1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wave"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""Scar"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibers"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Cellular_component""}]"
ADAM - 9 is expressed in human melanoma at the tumor - stroma border where direct or indirect interactions between tumor cells and fibroblasts occur.	"ADAM - 9	0	8	Gene_or_gene_product"	"human	25	30	Organism"	"melanoma	31	39	Cancer"	"tumor - stroma border	47	68	Tissue"	"tumor cells	115	126	Cell"	"fibroblasts	131	142	Cell"	"[{""token"": ""ADAM - 9"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""tumor - stroma border"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Tissue""}, {""token"": ""tumor cells"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Cell""}]"
To analyze the role of ADAM - 9 for the interaction between melanoma cells and stromal fibroblasts, we produced the recombinant disintegrin - like and cysteine - rich domain of ADAM - 9 ( DC - 9).	"ADAM - 9	23	31	Gene_or_gene_product"	"melanoma cells	60	74	Cell"	"stromal fibroblasts	79	98	Cell"	"disintegrin	128	139	Gene_or_gene_product"	"cysteine	151	159	Amino_acid"	"ADAM - 9	177	185	Gene_or_gene_product"	"[{""token"": ""ADAM - 9"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma cells"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""stromal fibroblasts"", ""start_span"": 79, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""disintegrin"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""cysteine"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Amino_acid""}, {""token"": ""ADAM - 9"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"
In summary, these results suggest that ADAM - 9 expression plays an important role in mediating cell - cell contacts between fibroblasts and melanoma cells and that these interactions contribute to proteolytic activities required during invasion of melanoma cells.	"ADAM - 9	39	47	Gene_or_gene_product"	"cell	96	100	Cell"	"cell	103	107	Cell"	"fibroblasts	125	136	Cell"	"melanoma cells	141	155	Cell"	"melanoma cells	249	263	Cell"	"[{""token"": ""ADAM - 9"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""melanoma cells"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""melanoma cells"", ""start_span"": 249, ""end_span"": 263, ""type"": ""Cell""}]"
Patients having low sVAP - 1 levels had significantly poorer prognosis relative to patients having elevated sVAP - 1 in all or stages I - III gastric cancer patients, respectively.	"Patients	0	8	Organism"	"sVAP - 1	20	28	Gene_or_gene_product"	"patients	83	91	Organism"	"sVAP - 1	108	116	Gene_or_gene_product"	"gastric cancer	142	156	Cancer"	"patients	157	165	Organism"	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""sVAP - 1"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""sVAP - 1"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Organism""}]"
Using human neuroblastoma cell line, SK - N - MC, we found that treatment of these cells with FGF - 2 resulted in early induction of both Id - 1 mRNA and protein.	"human	6	11	Organism"	"neuroblastoma cell line	12	35	Cell"	"SK - N - MC	37	48	Cell"	"cells	83	88	Cell"	"FGF - 2	94	101	Gene_or_gene_product"	"Id - 1	138	144	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""neuroblastoma cell line"", ""start_span"": 12, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""SK - N - MC"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""FGF - 2"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id - 1"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Epstein - Barr virus ( EBV) transforms B lymphocytes through the expression of the latent viral proteins EBNA and latent membrane protein ( LMP).	"Epstein - Barr virus	0	20	Organism"	"EBV	23	26	Organism"	"B lymphocytes	39	52	Cell"	"EBNA	105	109	Gene_or_gene_product"	"latent membrane protein	114	137	Gene_or_gene_product"	"LMP	140	143	Gene_or_gene_product"	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""B lymphocytes"", ""start_span"": 39, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""EBNA"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""latent membrane protein"", ""start_span"": 114, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"
Knockdown of VEGFR - 2 attenuated the sunitinib - induced effects, including apoptosis and inhibition of signaling pathways such as the phosphorylation of Akt as well as mTOR, and Bcl - 2, which confirmed that these effects could be mediated by VEGFR - 2.	"VEGFR - 2	13	22	Gene_or_gene_product"	"sunitinib	38	47	Chemical"	"Akt	155	158	Gene_or_gene_product"	"mTOR	170	174	Gene_or_gene_product"	"Bcl - 2	180	187	Gene_or_gene_product"	"VEGFR - 2	245	254	Gene_or_gene_product"	"[{""token"": ""VEGFR - 2"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""sunitinib"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 245, ""end_span"": 254, ""type"": ""Gene_or_gene_product""}]"
To analyze the contribution of VEGF - C to lymph node metastasis, its corresponding gene was stably introduced into HEC1A cells ( HEC1A / VEGF - C), which then produced more than 10 times the amount of VEGF - C.	"VEGF - C	31	39	Gene_or_gene_product"	"lymph node	43	53	Multi"	"HEC1A cells	116	127	Cell"	"HEC1A	130	135	Cell"	"VEGF - C	138	146	Gene_or_gene_product"	"VEGF - C	202	210	Gene_or_gene_product"	"[{""token"": ""VEGF - C"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Multi""}, {""token"": ""HEC1A cells"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""HEC1A"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}]"
Cooperative transformation by c - MYC and OSM required PI3K and AKT signaling, showing the importance of multiple signaling pathways downstream of the OSM receptor in defining the cellular response to cytokines.	"c - MYC	30	37	Gene_or_gene_product"	"OSM	42	45	Gene_or_gene_product"	"PI3K	55	59	Gene_or_gene_product"	"AKT	64	67	Gene_or_gene_product"	"OSM receptor	151	163	Gene_or_gene_product"	"cellular	180	188	Cell"	"[{""token"": ""c - MYC"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM receptor"", ""start_span"": 151, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Cell""}]"
The NBD peptide suppressed metastasis and tongue tumor growth in GSAS / N5 - inoculated mice, and was accompanied by the downregulation of the NF - kappaB - regulated metastasis - related molecules in engrafted tongue tumors.	"NBD peptide	4	15	Chemical"	"tongue tumor	42	54	Cancer"	"GSAS / N5	65	74	Cell"	"mice	88	92	Organism"	"NF - kappaB	143	154	Gene_or_gene_product"	"tongue tumors	211	224	Cancer"	"[{""token"": ""NBD peptide"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""tongue tumor"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""GSAS / N5"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""NF - kappaB"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""tongue tumors"", ""start_span"": 211, ""end_span"": 224, ""type"": ""Cancer""}]"
In addition to altering metastasis, beta - catenin levels control tumor differentiation and regulate both MAPK / Erk and PI3K / Akt signaling.	"beta - catenin	36	50	Gene_or_gene_product"	"tumor	66	71	Cancer"	"MAPK	106	110	Gene_or_gene_product"	"Erk	113	116	Gene_or_gene_product"	"PI3K	121	125	Gene_or_gene_product"	"Akt	128	131	Gene_or_gene_product"	"[{""token"": ""beta - catenin"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""MAPK"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erk"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"
Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models.	"Mitochondrial	0	13	Cellular_component"	"FAK	28	31	Gene_or_gene_product"	"histone deacetylase	64	83	Gene_or_gene_product"	"HTPB	95	99	Chemical"	"antitumor	104	113	Cancer"	"mouse	133	138	Organism"	"[{""token"": ""Mitochondrial"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cellular_component""}, {""token"": ""FAK"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""histone deacetylase"", ""start_span"": 64, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTPB"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism""}]"
Moreover, HTPB inhibited activity of MMP2 and MMP9, reduced integrin - beta1 / focal adhesion complex formation and decreased pericellular poly - fibronectin assemblies.	"HTPB	10	14	Chemical"	"MMP2	37	41	Gene_or_gene_product"	"MMP9	46	50	Gene_or_gene_product"	"integrin - beta1	60	76	Gene_or_gene_product"	"focal adhesion complex	79	101	Gene_or_gene_product"	"fibronectin	146	157	Gene_or_gene_product"	"[{""token"": ""HTPB"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""MMP2"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP9"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin - beta1"", ""start_span"": 60, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesion complex"", ""start_span"": 79, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}]"
On the contrary, there was intense staining for HER2 on the basolateral membrane of epithelial cells of intestinal metaplasia ( 22 / 24; 91. 7%) and carcinoma in situ ( 9 / 10; 90%), the lesions that displayed a significantly high proliferation index.	"HER2	48	52	Gene_or_gene_product"	"basolateral membrane	60	80	Cellular_component"	"epithelial cells	84	100	Cell"	"intestinal metaplasia	104	125	Cancer"	"carcinoma	149	158	Cancer"	"lesions	187	194	Pathological_formation"	"[{""token"": ""HER2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""basolateral membrane"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Cellular_component""}, {""token"": ""epithelial cells"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""intestinal metaplasia"", ""start_span"": 104, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""carcinoma"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Cancer""}, {""token"": ""lesions"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Pathological_formation""}]"
Plasminogen activator ( PA) content of excised tumors was determined by SDS - PAGE, and major PA was found to be urokinase ( UK) type.	"Plasminogen activator	0	21	Gene_or_gene_product"	"PA	24	26	Gene_or_gene_product"	"tumors	47	53	Cancer"	"PA	78	80	Gene_or_gene_product"	"urokinase	113	122	Gene_or_gene_product"	"UK	125	127	Gene_or_gene_product"	"[{""token"": ""Plasminogen activator"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""PA"", ""start_span"": 24, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""PA"", ""start_span"": 78, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""urokinase"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""UK"", ""start_span"": 125, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"
When tumor cells possessed a high level of UK, laminin and type IV collagen, components of the basement membrane, disappeared from tumor tissues.	"tumor cells	5	16	Cell"	"UK	43	45	Gene_or_gene_product"	"laminin	47	54	Gene_or_gene_product"	"type IV collagen	59	75	Gene_or_gene_product"	"basement membrane	95	112	Cellular_component"	"tumor tissues	131	144	Tissue"	"[{""token"": ""tumor cells"", ""start_span"": 5, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""UK"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""laminin"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagen"", ""start_span"": 59, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""basement membrane"", ""start_span"": 95, ""end_span"": 112, ""type"": ""Cellular_component""}, {""token"": ""tumor tissues"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Tissue""}]"
Clinically, patients with advanced cancer are usually in a hypercoagulable state with elevated fibrinogen, and fibrin deposition around tumor mass is a serious problem in cancer chemotherapy.	"patients	12	20	Organism"	"advanced cancer	26	41	Cancer"	"fibrinogen	95	105	Gene_or_gene_product"	"fibrin	111	117	Gene_or_gene_product"	"tumor	136	141	Cancer"	"cancer	171	177	Cancer"	"[{""token"": ""patients"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""advanced cancer"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""fibrinogen"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrin"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Cancer""}]"
This enhanced glycolysis was partly sensitive to rutamycin and partly sensitive to ouabain, suggesting that the detergent released the control of the ATPase of the mitochondria and of the plasma membrane Na + K + - ATPase.	"rutamycin	49	58	Chemical"	"ouabain	83	90	Chemical"	"ATPase	150	156	Gene_or_gene_product"	"mitochondria	164	176	Cellular_component"	"plasma membrane	188	203	Cellular_component"	"Na + K + - ATPase	204	221	Gene_or_gene_product"	"[{""token"": ""rutamycin"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""ouabain"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""ATPase"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Cellular_component""}, {""token"": ""plasma membrane"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Cellular_component""}, {""token"": ""Na + K + - ATPase"", ""start_span"": 204, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}]"
In down modulated growing cells, PDBu caused almost complete inhibition of EGF binding, whereas in down modulated stationary cells, minimal inhibition of EGF binding by PDBu was observed.	"cells	26	31	Cell"	"PDBu	33	37	Chemical"	"EGF	75	78	Gene_or_gene_product"	"cells	125	130	Cell"	"EGF	154	157	Gene_or_gene_product"	"PDBu	169	173	Chemical"	"[{""token"": ""cells"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""PDBu"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""EGF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""EGF"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDBu"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Chemical""}]"
Rat - 1 cells which had been transformed with the activated Ha - ras - 1 gene from human EJ bladder carcinoma cells were fused with diploid embryonic rat fibroblasts.	"Rat - 1 cells	0	13	Cell"	"Ha - ras - 1	60	72	Gene_or_gene_product"	"human	83	88	Organism"	"EJ bladder carcinoma cells	89	115	Cell"	"rat	150	153	Organism"	"fibroblasts	154	165	Cell"	"[{""token"": ""Rat - 1 cells"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""Ha - ras - 1"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""EJ bladder carcinoma cells"", ""start_span"": 89, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Cell""}]"
DNA of the non - tumorigenic cell hybrids transformed Rat - 1 cells to anchorage - independent proliferation as expected for the transforming human Ha - ras gene present in the donor DNA.	"DNA	0	3	Cellular_component"	"cell hybrids	29	41	Cell"	"Rat - 1 cells	54	67	Cell"	"human	142	147	Organism"	"Ha - ras	148	156	Gene_or_gene_product"	"DNA	183	186	Cellular_component"	"[{""token"": ""DNA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cellular_component""}, {""token"": ""cell hybrids"", ""start_span"": 29, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""Rat - 1 cells"", ""start_span"": 54, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Organism""}, {""token"": ""Ha - ras"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Cellular_component""}]"
"Their genomes are relatively simple, containing the genes gag, pol, env, and a 3 ' region termed "" X. "" This 3 ' region may be responsible for the transforming potential of the viruses."	"gag	58	61	Gene_or_gene_product"	"pol	63	66	Gene_or_gene_product"	"env	68	71	Gene_or_gene_product"	"3 ' region	79	89	Cellular_component"	"X	99	100	Cellular_component"	"3 ' region	109	119	Cellular_component"	"[{""token"": ""gag"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""pol"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""env"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""3 ' region"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Cellular_component""}, {""token"": ""X"", ""start_span"": 99, ""end_span"": 100, ""type"": ""Cellular_component""}, {""token"": ""3 ' region"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Cellular_component""}]"
Experiments using the tsA 58 allele of the SV 40 - A gene have demonstrated that the SV 40 large T - antigen is strictly required both for immortalization and induction anchorage independence of cells.	"tsA 58	22	28	Gene_or_gene_product"	"SV 40	43	48	Organism"	"A	51	52	Gene_or_gene_product"	"SV 40	85	90	Organism"	"large T - antigen	91	108	Gene_or_gene_product"	"cells	195	200	Cell"	"[{""token"": ""tsA 58"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV 40"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""A"", ""start_span"": 51, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV 40"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism""}, {""token"": ""large T - antigen"", ""start_span"": 91, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 195, ""end_span"": 200, ""type"": ""Cell""}]"
In DNA from the T - cells not expressing DR alpha mRNA, all of the potential HpaII sites within the BglII fragment appeared to be methylated.	"DNA	3	6	Cellular_component"	"T - cells	16	25	Cell"	"DR alpha	41	49	Gene_or_gene_product"	"HpaII	77	82	Gene_or_gene_product"	"BglII	100	105	Gene_or_gene_product"	"fragment	106	114	Cellular_component"	"[{""token"": ""DNA"", ""start_span"": 3, ""end_span"": 6, ""type"": ""Cellular_component""}, {""token"": ""T - cells"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""DR alpha"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""HpaII"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""BglII"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""fragment"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Cellular_component""}]"
Treatment of these T - cells with 5 - azacytidine resulted in the induction of DR surface antigen expression, the appearance of DR alpha mRNA, and the partial demethylation of the DR alpha DNA sequences.	"T - cells	19	28	Cell"	"5 - azacytidine	34	49	Chemical"	"DR surface antigen	79	97	Gene_or_gene_product"	"DR alpha	128	136	Gene_or_gene_product"	"DR alpha	180	188	Gene_or_gene_product"	"DNA	189	192	Cellular_component"	"[{""token"": ""T - cells"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""5 - azacytidine"", ""start_span"": 34, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""DR surface antigen"", ""start_span"": 79, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Cellular_component""}]"
Uncultured peripheral blood T - cells from human T - cell leukemia - lymphoma virus - infected individuals expressed DR antigens at a low level, and the DR alpha locus was partially unmethylated.	"peripheral blood T - cells	11	37	Cell"	"human T - cell leukemia - lymphoma virus	43	83	Organism"	"individuals	95	106	Organism"	"DR antigens	117	128	Gene_or_gene_product"	"DR alpha	153	161	Gene_or_gene_product"	"locus	162	167	Cellular_component"	"[{""token"": ""peripheral blood T - cells"", ""start_span"": 11, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""human T - cell leukemia - lymphoma virus"", ""start_span"": 43, ""end_span"": 83, ""type"": ""Organism""}, {""token"": ""individuals"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""DR antigens"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""locus"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Cellular_component""}]"
The parameters considered are the number of platelets and their aggregability, prothrombin and partial thromboplastin times, plasma fibrinogen concentration and tumor cell procoagulant activity.	"platelets	44	53	Cell"	"prothrombin	79	90	Gene_or_gene_product"	"thromboplastin	103	117	Gene_or_gene_product"	"plasma	125	131	Organism_substance"	"fibrinogen	132	142	Gene_or_gene_product"	"tumor cell	161	171	Cell"	"[{""token"": ""platelets"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""prothrombin"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""thromboplastin"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Organism_substance""}, {""token"": ""fibrinogen"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Cell""}]"
The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up - regulation and is not exerted by transformation - competent cytoplasmic mutants.	"myoblast	27	35	Cell"	"simian virus 40	59	74	Organism"	"large T antigen	75	90	Gene_or_gene_product"	"myogenin	104	112	Gene_or_gene_product"	"Rb	128	130	Gene_or_gene_product"	"cytoplasmic	196	207	Organism_substance"	"[{""token"": ""myoblast"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""simian virus 40"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""large T antigen"", ""start_span"": 75, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""myogenin"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 128, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 196, ""end_span"": 207, ""type"": ""Organism_substance""}]"
The inhibiting mutants, including the Rb binding site mutant, were able to promote a higher state of Rb phosphorylation than that observed in either normal cells or cytoplasmic - SVLT transformants.	"Rb	38	40	Gene_or_gene_product"	"Rb	101	103	Gene_or_gene_product"	"cells	156	161	Cell"	"cytoplasmic	165	176	Organism_substance"	"SVLT	179	183	Gene_or_gene_product"	"transformants	184	197	Cell"	"[{""token"": ""Rb"", ""start_span"": 38, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""cytoplasmic"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Organism_substance""}, {""token"": ""SVLT"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""transformants"", ""start_span"": 184, ""end_span"": 197, ""type"": ""Cell""}]"
Intraperitoneal injections of 2G7 starting 1 d after intraperitoneal inoculation of tumor cells suppressed intraabdominal tumor and lung metastases, whereas the nonneutralizing anti - TGF - beta 12H5 IgG2a had no effect.	"Intraperitoneal	0	15	Immaterial_anatomical_entity"	"intraperitoneal	53	68	Immaterial_anatomical_entity"	"tumor cells	84	95	Cell"	"intraabdominal tumor	107	127	Cancer"	"lung	132	136	Organ"	"TGF - beta	184	194	Gene_or_gene_product"	"[{""token"": ""Intraperitoneal"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intraperitoneal"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""tumor cells"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""intraabdominal tumor"", ""start_span"": 107, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organ""}, {""token"": ""TGF - beta"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"
Both the erbA IRES and the erbA / myb IRES virus constructs transformed erythroid cells after infection of bone marrow or blastoderm cultures.	"erbA	9	13	Gene_or_gene_product"	"erbA	27	31	Gene_or_gene_product"	"myb	34	37	Gene_or_gene_product"	"erythroid cells	72	87	Cell"	"bone marrow	107	118	Multi"	"blastoderm cultures	122	141	Cell"	"[{""token"": ""erbA"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""myb"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroid cells"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""blastoderm cultures"", ""start_span"": 122, ""end_span"": 141, ""type"": ""Cell""}]"
Assessment of starved HUVECs at 14 days demonstrated sixfold more cells for AdCMV. VEGF165 - infected HUVECs ( 20 pfu per cell) than for either infected or uninfected control cells.	"HUVECs	22	28	Cell"	"cells	66	71	Cell"	"VEGF165	83	90	Gene_or_gene_product"	"HUVECs	102	108	Cell"	"cell	122	126	Cell"	"cells	175	180	Cell"	"[{""token"": ""HUVECs"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVECs"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Cell""}]"
When plated in 2% serum on dishes precoated with reconstituted basement membrane ( Matrigel), HUVECs infected with AdCMV. VEGF165 ( 20 pfu per cell) differentiated into capillary - like structures.	"serum	18	23	Organism_substance"	"basement membrane	63	80	Cellular_component"	"HUVECs	94	100	Cell"	"VEGF165	122	129	Gene_or_gene_product"	"cell	143	147	Cell"	"capillary - like structures	169	196	Tissue"	"[{""token"": ""serum"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Organism_substance""}, {""token"": ""basement membrane"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cellular_component""}, {""token"": ""HUVECs"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""capillary - like structures"", ""start_span"": 169, ""end_span"": 196, ""type"": ""Tissue""}]"
When the macro - molecular synthesis inhibitor cycloheximide ( CHX) or actinomycin D ( Act D) was present for 26 hours in the absence of GM - CSF and FBS, apoptosis was inhibited.	"cycloheximide	47	60	Chemical"	"CHX	63	66	Chemical"	"actinomycin D	71	84	Chemical"	"Act D	87	92	Chemical"	"GM - CSF	137	145	Gene_or_gene_product"	"FBS	150	153	Organism_substance"	"[{""token"": ""cycloheximide"", ""start_span"": 47, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""CHX"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""actinomycin D"", ""start_span"": 71, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""Act D"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""GM - CSF"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBS"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Organism_substance""}]"
Tetracyclines are antimicrobial agents that can suppress MP activity in a variety of tissues, including gingiva, bone, and cartilage.	"Tetracyclines	0	13	Chemical"	"MP	57	59	Gene_or_gene_product"	"tissues	85	92	Tissue"	"gingiva	104	111	Multi"	"bone	113	117	Tissue"	"cartilage	123	132	Tissue"	"[{""token"": ""Tetracyclines"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""MP"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Tissue""}, {""token"": ""gingiva"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""bone"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Tissue""}, {""token"": ""cartilage"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Tissue""}]"
These TGF - beta - resistant cells also exhibited progressively increasing levels of expression of the c - fos and and myc mRNA, and increased resistance to the cytotoxicity of Adriamycin and melphalan.	"TGF - beta	6	16	Gene_or_gene_product"	"cells	29	34	Cell"	"c - fos	103	110	Gene_or_gene_product"	"myc	119	122	Gene_or_gene_product"	"Adriamycin	177	187	Chemical"	"melphalan	192	201	Chemical"	"[{""token"": ""TGF - beta"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""c - fos"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""myc"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Adriamycin"", ""start_span"": 177, ""end_span"": 187, ""type"": ""Chemical""}, {""token"": ""melphalan"", ""start_span"": 192, ""end_span"": 201, ""type"": ""Chemical""}]"
Two small RNAs ( 0. 9 and 0. 75 kb), named Marek ' s disease virus ( MDV) small RNAs ( MSRs) and a 10 - kb RNA, all of which map antisense to the MDV ICP4 homolog gene, have been readily detected in MDCC - MSB1 MDV - transformed T - lymphoblastoid cells.	"MSRs	87	91	Gene_or_gene_product"	"MDV	146	149	Organism"	"ICP4 homolog	150	162	Gene_or_gene_product"	"MDCC - MSB1	199	210	Cell"	"MDV	211	214	Organism"	"T - lymphoblastoid cells	229	253	Cell"	"[{""token"": ""MSRs"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDV"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Organism""}, {""token"": ""ICP4 homolog"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDCC - MSB1"", ""start_span"": 199, ""end_span"": 210, ""type"": ""Cell""}, {""token"": ""MDV"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Organism""}, {""token"": ""T - lymphoblastoid cells"", ""start_span"": 229, ""end_span"": 253, ""type"": ""Cell""}]"
Importantly, a striking increase in the expression of specific PTPases, LAR and PTP1B, was observed in 3 independently neu transformed cell lines and their derived tumors.	"PTPases	63	70	Gene_or_gene_product"	"LAR	72	75	Gene_or_gene_product"	"PTP1B	80	85	Gene_or_gene_product"	"neu	119	122	Gene_or_gene_product"	"cell lines	135	145	Cell"	"tumors	164	170	Cancer"	"[{""token"": ""PTPases"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAR"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTP1B"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cancer""}]"
Thus, our results provide the first evidence that, in human breast carcinoma cells and in rat mammary carcinomas that have an induced increase in neu expression, a consistent and substantial increase in the expression of specific PTPases occurs.	"human	54	59	Organism"	"breast carcinoma cells	60	82	Cell"	"rat	90	93	Organism"	"mammary carcinomas	94	112	Cancer"	"neu	146	149	Gene_or_gene_product"	"PTPases	230	237	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""breast carcinoma cells"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""mammary carcinomas"", ""start_span"": 94, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""neu"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTPases"", ""start_span"": 230, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"
In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma.	"insulin	19	26	Gene_or_gene_product"	"tumor	30	35	Cancer"	"skeletal muscle	40	55	Tissue"	"glucose	56	63	Chemical"	"patients	78	86	Organism"	"lymphoma	92	100	Cancer"	"[{""token"": ""insulin"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""skeletal muscle"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Tissue""}, {""token"": ""glucose"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Cancer""}]"
Whole body glucose use was 55% lower in patients than in control subjects ( 17 + / - 3 mumol / kg / minute versus 38 + / - 3 mumol / kg / minute, P = 0. 002), consistent with insulin resistance in cancer.	"body	6	10	Organism_subdivision"	"glucose	11	18	Chemical"	"patients	40	48	Organism"	"control subjects	57	73	Organism"	"insulin	175	182	Gene_or_gene_product"	"cancer	197	203	Cancer"	"[{""token"": ""body"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Organism_subdivision""}, {""token"": ""glucose"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""control subjects"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""insulin"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Cancer""}]"
In spite of uncertainties regarding the mechanisms of carcinogenesis, several vitamins such as beta - carotene and vitamins A, C, and E, which can reduce the risk of cancer, have been identified, using animal and in vitro models of carcinogenesis.	"vitamins	78	86	Chemical"	"beta - carotene	95	110	Chemical"	"vitamins A	115	125	Chemical"	"C	127	128	Chemical"	"E	134	135	Chemical"	"cancer	166	172	Cancer"	"[{""token"": ""vitamins"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""beta - carotene"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""vitamins A"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""C"", ""start_span"": 127, ""end_span"": 128, ""type"": ""Chemical""}, {""token"": ""E"", ""start_span"": 134, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Cancer""}]"
The fact that some vitamins induce cell differentiation and / or growth inhibition in tumor cells in culture suggests that the use of these vitamins in cancer prevention has a cellular basis.	"vitamins	19	27	Chemical"	"cell	35	39	Cell"	"tumor cells	86	97	Cell"	"vitamins	140	148	Chemical"	"cancer	152	158	Cancer"	"cellular	176	184	Cell"	"[{""token"": ""vitamins"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""vitamins"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Cancer""}, {""token"": ""cellular"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Cell""}]"
Some vitamins like beta - carotene, retinoic acid, alpha - tocopheryl succinate, and vitamin D also regulate the expressions of certain oncogenes and cellular genes.	"vitamins	5	13	Chemical"	"beta - carotene	19	34	Chemical"	"retinoic acid	36	49	Chemical"	"alpha - tocopheryl succinate	51	79	Chemical"	"vitamin D	85	94	Chemical"	"cellular	150	158	Cell"	"[{""token"": ""vitamins"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""beta - carotene"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""retinoic acid"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""alpha - tocopheryl succinate"", ""start_span"": 51, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""vitamin D"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""cellular"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Cell""}]"
More recent data have demonstrated the existence of two human nm23 gene homologues, nm23 - H1 and nm23 - H2, and have shown that deletion of nm23 - H1 alleles occurs in some colon carcinomas associated with poor prognosis.	"human	56	61	Organism"	"nm23	62	66	Gene_or_gene_product"	"nm23 - H1	84	93	Gene_or_gene_product"	"nm23 - H2	98	107	Gene_or_gene_product"	"nm23 - H1	141	150	Gene_or_gene_product"	"colon carcinomas	174	190	Cancer"	"[{""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""nm23"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H1"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H1"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon carcinomas"", ""start_span"": 174, ""end_span"": 190, ""type"": ""Cancer""}]"
To assess the lymphoid tumorigenic potential of bcl - 2, mice of five independent strains expressing a bcl - 2 transgene in B and / or T cells were monitored for disease up to 12 months of age.	"lymphoid	14	22	Cell"	"bcl - 2	48	55	Gene_or_gene_product"	"mice	57	61	Organism"	"bcl - 2	103	110	Gene_or_gene_product"	"B	124	125	Cell"	"T cells	135	142	Cell"	"[{""token"": ""lymphoid"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""bcl - 2"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""bcl - 2"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""B"", ""start_span"": 124, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""T cells"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Cell""}]"
Gangliocytic paraganglioma ( GPG) with local lymph node metastasis was found in the pancreas of a 74 - yr - old female who presented with diarrhea, steatorrhea, vomiting, nausea, and abdominal pain.	"Gangliocytic paraganglioma	0	26	Cancer"	"GPG	29	32	Cancer"	"lymph node	45	55	Multi"	"pancreas	84	92	Organ"	"female	112	118	Organism"	"abdominal	183	192	Organism_subdivision"	"[{""token"": ""Gangliocytic paraganglioma"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Cancer""}, {""token"": ""GPG"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""pancreas"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Organ""}, {""token"": ""female"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""abdominal"", ""start_span"": 183, ""end_span"": 192, ""type"": ""Organism_subdivision""}]"
Stimulation of endothelial cell migration by vascular permeability factor / vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.	"endothelial cell	15	31	Cell"	"vascular permeability factor	45	73	Gene_or_gene_product"	"vascular endothelial growth factor	76	110	Gene_or_gene_product"	"alphavbeta3 integrin	156	176	Gene_or_gene_product"	"osteopontin	178	189	Gene_or_gene_product"	"thrombin	195	203	Gene_or_gene_product"	"[{""token"": ""endothelial cell"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""vascular permeability factor"", ""start_span"": 45, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 76, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3 integrin"", ""start_span"": 156, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteopontin"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"
We have identified several mechanisms by which the angiogenic cytokine vascular permeability factor / vascular endothelial growth factor ( VPF / VEGF) likely regulates endothelial cells ( EC) migration.	"vascular permeability factor	71	99	Gene_or_gene_product"	"vascular endothelial growth factor	102	136	Gene_or_gene_product"	"VPF	139	142	Gene_or_gene_product"	"VEGF	145	149	Gene_or_gene_product"	"endothelial cells	168	185	Cell"	"EC	188	190	Cell"	"[{""token"": ""vascular permeability factor"", ""start_span"": 71, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 102, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""VPF"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 168, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 188, ""end_span"": 190, ""type"": ""Cell""}]"
Upon retroviral transduction of the mouse c - myc gene, Rat 6 cells showed mildly altered morphology and formed microcolonies in soft agar; furthermore, they could be transformed by BP and MNNG to form large colonies in agar ( Hsiao et al. ( 1992) Mol. Carcinogenesis, 5, 140 - 154).	"retroviral	5	15	Organism"	"mouse	36	41	Organism"	"c - myc	42	49	Gene_or_gene_product"	"Rat 6 cells	56	67	Cell"	"BP	182	184	Chemical"	"MNNG	189	193	Chemical"	"[{""token"": ""retroviral"", ""start_span"": 5, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""c - myc"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rat 6 cells"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""BP"", ""start_span"": 182, ""end_span"": 184, ""type"": ""Chemical""}, {""token"": ""MNNG"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Chemical""}]"
E1A proteins stimulate DNA synthesis and cell proliferation; however, they also cause rapid cell death by p53 - dependent and p53 - independent apoptosis.	"E1A	0	3	Gene_or_gene_product"	"DNA	23	26	Cellular_component"	"cell	41	45	Cell"	"cell	92	96	Cell"	"p53	106	109	Gene_or_gene_product"	"p53	126	129	Gene_or_gene_product"	"[{""token"": ""E1A"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"
Apoptosis is a regulated form of cell death that may be triggered by natural killer ( NK) or cytotoxic T cells, which effect target cell lysis by cytolytic effector and related proteins through complex intracellular signals.	"cell	33	37	Cell"	"natural killer	69	83	Cell"	"NK	86	88	Cell"	"cytotoxic T cells	93	110	Cell"	"cell	132	136	Cell"	"intracellular	202	215	Immaterial_anatomical_entity"	"[{""token"": ""cell"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""natural killer"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""NK"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""cytotoxic T cells"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""intracellular"", ""start_span"": 202, ""end_span"": 215, ""type"": ""Immaterial_anatomical_entity""}]"
CONCLUSION: In MEN II A patients undergoing prophylactic thyroidectomy, baseline but not stimulated calcitonin levels already correlate with the histologic tumor stage at the stage of clinically occult C - cell hyperplasia or medullary microcarcinoma.	"MEN II A	15	23	Cancer"	"patients	24	32	Organism"	"calcitonin	100	110	Gene_or_gene_product"	"tumor	156	161	Cancer"	"C - cell	202	210	Cell"	"medullary microcarcinoma	226	250	Cancer"	"[{""token"": ""MEN II A"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""calcitonin"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Cancer""}, {""token"": ""C - cell"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Cell""}, {""token"": ""medullary microcarcinoma"", ""start_span"": 226, ""end_span"": 250, ""type"": ""Cancer""}]"
When a confluent monolayer of human umbilical vein endothelial cell line, ECV304, was denuded, ECV304 at the wound edge expressed Ets - 1.	"monolayer	17	26	Cell"	"human umbilical vein endothelial cell line	30	72	Cell"	"ECV304	74	80	Cell"	"ECV304	95	101	Cell"	"wound edge	109	119	Pathological_formation"	"Ets - 1	130	137	Gene_or_gene_product"	"[{""token"": ""monolayer"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""human umbilical vein endothelial cell line"", ""start_span"": 30, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""ECV304"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""ECV304"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""wound edge"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Pathological_formation""}, {""token"": ""Ets - 1"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"
Their resistance to the anti - invasive action of TGFbeta was explained by the failure of TGFbeta to upregulate TIMPs and PAI - I, in contrast to the TGFbeta - induced upregulation noted in parental HTR8 cells.	"TGFbeta	50	57	Gene_or_gene_product"	"TGFbeta	90	97	Gene_or_gene_product"	"TIMPs	112	117	Gene_or_gene_product"	"PAI - I	122	129	Gene_or_gene_product"	"TGFbeta	150	157	Gene_or_gene_product"	"HTR8 cells	199	209	Cell"	"[{""token"": ""TGFbeta"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFbeta"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMPs"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - I"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFbeta"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTR8 cells"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Cell""}]"
Our study indicates that 1) Ca2 + entry in pulmonary endothelial cells through SOCs produces cell shape change that is dependent on site - specific rearrangement of the microfilamentous cytoskeleton and 2) Trp1 may be a component of pulmonary endothelial SOCs.	"Ca2 +	28	33	Chemical"	"pulmonary endothelial cells	43	70	Cell"	"cell	93	97	Cell"	"microfilamentous cytoskeleton	169	198	Cellular_component"	"Trp1	206	210	Gene_or_gene_product"	"pulmonary endothelial	233	254	Cell"	"[{""token"": ""Ca2 +"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""pulmonary endothelial cells"", ""start_span"": 43, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""microfilamentous cytoskeleton"", ""start_span"": 169, ""end_span"": 198, ""type"": ""Cellular_component""}, {""token"": ""Trp1"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}, {""token"": ""pulmonary endothelial"", ""start_span"": 233, ""end_span"": 254, ""type"": ""Cell""}]"
Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase - related protein 1 / SV40 T antigen transgenic mice.	"Tumors	0	6	Cancer"	"retinal pigment epithelium	14	40	Tissue"	"lymph nodes	65	76	Multi"	"spleen	81	87	Organ"	"tyrosinase - related protein 1	91	121	Gene_or_gene_product"	"SV40 T antigen	124	138	Gene_or_gene_product"	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""retinal pigment epithelium"", ""start_span"": 14, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""lymph nodes"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Multi""}, {""token"": ""spleen"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Organ""}, {""token"": ""tyrosinase - related protein 1"", ""start_span"": 91, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40 T antigen"", ""start_span"": 124, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}]"
In spleen, tyrosinase, TRP - 1 and SV40 Tag were expressed and tyrosinase was enzymatically active.	"spleen	3	9	Organ"	"tyrosinase	11	21	Gene_or_gene_product"	"TRP - 1	23	30	Gene_or_gene_product"	"SV40	35	39	Organism"	"Tag	40	43	Gene_or_gene_product"	"tyrosinase	63	73	Gene_or_gene_product"	"[{""token"": ""spleen"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Organ""}, {""token"": ""tyrosinase"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRP - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosinase"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"
In conclusion, the metastasis from TRP - 1 / Tag RPE tumors towards spleen and lymph nodes serves as potential tool to investigate biology and metastasis of tumors derived from the pigment epithelium.	"TRP - 1	35	42	Gene_or_gene_product"	"Tag	45	48	Gene_or_gene_product"	"spleen	68	74	Organ"	"lymph nodes	79	90	Multi"	"tumors	157	163	Cancer"	"pigment epithelium	181	199	Tissue"	"[{""token"": ""TRP - 1"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tag"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""spleen"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Organ""}, {""token"": ""lymph nodes"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Cancer""}, {""token"": ""pigment epithelium"", ""start_span"": 181, ""end_span"": 199, ""type"": ""Tissue""}]"
